age,sex,hospdead,dzgroup,edu,income,charges,race,sod,ph,glucose,bun,urine,adlp,adls,sfdm2,adlsc
62.84998,male,0.0,Lung Cancer,11.0,$11-$25k,9715.0,other,141.0,7.459961,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
60.33899,female,1.0,Cirrhosis,12.0,$11-$25k,34496.0,white,132.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
52.74698,female,0.0,Cirrhosis,12.0,under $11k,41094.0,white,134.0,7.459961,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
42.38498,female,0.0,Lung Cancer,11.0,under $11k,3075.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.88495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50127.0,white,143.0,7.509766,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
93.01599,male,1.0,Coma,14.0,under $11k,6884.0,white,140.0,7.65918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
62.37097,male,0.0,CHF,14.0,$25-$50k,30460.0,white,132.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
86.83899,male,0.0,CHF,12.0,under $11k,30460.0,white,139.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
85.65594,male,0.0,Lung Cancer,12.0,under $11k,25024.0,black,143.0,7.449219,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
42.25897,female,0.0,Colon Cancer,11.0,$25-$50k,9914.0,hispanic,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
47.94498,male,0.0,CHF,12.0,under $11k,15558.0,white,134.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
59.20099,male,1.0,Lung Cancer,14.0,under $11k,29388.0,white,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
29.002,female,0.0,Cirrhosis,16.0,$11-$25k,4353.0,white,130.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.14197,male,0.0,CHF,12.0,$11-$25k,19783.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
43.53998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,706577.0,white,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.7641602
58.823,female,0.0,Lung Cancer,12.0,>$50k,10758.0,white,134.0,7.419922,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
45.418,male,0.0,Lung Cancer,12.0,under $11k,8400.0,white,137.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3515625
63.66299,female,1.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,283303.0,white,130.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.84399,male,1.0,Cirrhosis,16.0,under $11k,27985.0,white,122.0,7.419922,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
55.13797,male,0.0,CHF,8.0,$11-$25k,18191.0,hispanic,134.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),2.5110989
68.25494,male,0.0,Lung Cancer,13.0,>$50k,10755.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.70398,male,0.0,Lung Cancer,16.0,under $11k,55384.0,other,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2636719
49.61298,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,542266.0,white,130.0,7.399414,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
50.724,female,0.0,Lung Cancer,12.0,$25-$50k,4913.0,asian,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.065918
29.36099,female,0.0,Colon Cancer,17.0,$25-$50k,7792.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8149414
53.84,male,0.0,COPD,12.0,under $11k,9871.0,white,141.0,7.379883,135.0,23.0,1968.0,5.0,4.0,no(M2 and SIP pres),4.0
82.41498,female,1.0,Lung Cancer,12.0,under $11k,7212.0,white,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7041016
27.32399,male,1.0,MOSF w/Malig,19.0,under $11k,160060.0,asian,147.0,7.30957,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
30.10799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,57611.0,asian,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8461914
50.37097,male,0.0,Cirrhosis,16.0,$11-$25k,465380.0,white,138.0,7.319336,135.0,23.0,1968.0,3.0,1.0,SIP>=30,1.0
74.48297,male,0.0,CHF,16.0,>$50k,18134.0,white,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
55.73199,male,0.0,Cirrhosis,8.0,under $11k,52092.0,hispanic,117.0,7.379883,135.0,23.0,1968.0,7.0,6.0,SIP>=30,6.0
77.21295,female,0.0,COPD,0.0,under $11k,9078.0,hispanic,145.0,7.269531,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
61.02399,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,109627.0,white,143.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8251953
56.48999,female,0.0,CHF,12.0,under $11k,38548.0,hispanic,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0981445
57.53299,female,0.0,Cirrhosis,14.0,under $11k,156556.0,hispanic,132.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1318359
68.98596,female,0.0,COPD,10.0,under $11k,5763.0,white,142.0,7.359375,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
41.97897,male,0.0,CHF,14.0,$11-$25k,5552.0,white,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
19.79199,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,167971.0,black,131.0,7.439453,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
57.50897,female,0.0,CHF,14.0,under $11k,6403.0,black,138.0,7.449219,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
73.40698,male,0.0,Colon Cancer,12.0,under $11k,22934.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4677734
68.31799,male,0.0,Colon Cancer,21.0,>$50k,9205.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.79498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,271250.0,white,128.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6855469
45.71899,male,0.0,CHF,12.0,under $11k,115112.0,white,135.0,7.599609,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.48798,male,0.0,CHF,16.0,under $11k,120920.0,hispanic,124.0,7.429688,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
74.995,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,348931.0,white,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4423828
56.19397,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,230733.0,other,131.0,7.449219,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
44.849,female,0.0,MOSF w/Malig,10.0,$11-$25k,25176.0,hispanic,136.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
51.09698,female,0.0,CHF,11.0,under $11k,30877.0,black,140.0,7.459961,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
36.30899,male,0.0,CHF,16.0,under $11k,23476.0,white,121.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
76.25696,male,0.0,CHF,12.0,under $11k,14926.0,white,141.0,7.399414,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
51.30499,male,0.0,CHF,12.0,under $11k,52187.0,black,128.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
74.54297,female,0.0,COPD,12.0,under $11k,9631.0,white,137.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.30798,male,0.0,Lung Cancer,17.0,$25-$50k,29939.0,white,136.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.57697,female,0.0,CHF,12.0,under $11k,3124.0,other,139.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3085938
84.95795,male,0.0,CHF,14.0,>$50k,30942.0,white,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
41.52197,male,1.0,MOSF w/Malig,18.0,>$50k,320843.0,white,134.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.685,female,0.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,220639.0,white,139.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.55896,female,1.0,COPD,12.0,under $11k,4894.0,white,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9550781
60.10098,male,0.0,Cirrhosis,12.0,under $11k,63466.0,white,142.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3813477
70.81195,male,0.0,CHF,12.0,under $11k,6254.0,black,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5957031
30.76199,male,0.0,CHF,10.0,under $11k,8437.0,hispanic,133.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.23798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,321716.0,white,136.0,7.319336,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
51.70999,male,0.0,CHF,12.0,under $11k,31222.0,asian,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.64294,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,180786.0,white,133.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.41498,male,0.0,Lung Cancer,16.0,$25-$50k,8706.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
57.19098,male,0.0,CHF,12.0,$11-$25k,28476.0,white,126.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
37.73297,male,0.0,CHF,12.0,$25-$50k,26278.0,white,132.0,7.469727,135.0,23.0,1968.0,5.0,7.0,<2 mo. follow-up,7.0
44.05499,female,0.0,Colon Cancer,16.0,>$50k,18563.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.15594,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,187014.0,white,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7045898
45.56598,male,1.0,MOSF w/Malig,18.0,$25-$50k,181701.0,white,142.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
41.95999,male,0.0,Lung Cancer,16.0,>$50k,4173.0,white,133.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1796875
59.31,male,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,538692.0,white,142.0,7.509766,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
45.61499,female,1.0,Cirrhosis,16.0,>$50k,302353.0,white,139.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5454102
65.98499,female,0.0,Colon Cancer,12.0,under $11k,18980.0,hispanic,140.0,7.399414,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
95.79199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,74764.0,white,147.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.9414062
76.59094,male,0.0,Colon Cancer,17.0,$11-$25k,7137.0,white,146.0,7.439453,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
68.10095,male,0.0,CHF,12.0,$11-$25k,9586.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9719238
78.85297,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,39420.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.9472656
37.87,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,397017.0,white,134.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5400391
74.90997,female,0.0,COPD,16.0,under $11k,8166.0,white,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.702,female,0.0,Cirrhosis,14.0,under $11k,231119.0,black,127.0,7.489258,135.0,23.0,1968.0,6.0,1.0,SIP>=30,1.0
54.93997,female,0.0,CHF,14.0,$11-$25k,27561.0,white,136.0,7.459961,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
43.30197,male,1.0,Cirrhosis,14.0,under $11k,283145.0,hispanic,130.0,7.419922,135.0,23.0,1968.0,3.0,2.0,<2 mo. follow-up,2.0
54.92999,female,0.0,Lung Cancer,12.0,$25-$50k,15392.0,asian,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
70.21497,male,0.0,Colon Cancer,12.0,$11-$25k,8442.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.09399,female,0.0,Cirrhosis,3.0,under $11k,71992.0,black,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.05096,male,0.0,Cirrhosis,14.0,$25-$50k,14944.0,white,130.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
69.34698,male,1.0,MOSF w/Malig,18.0,under $11k,433684.0,asian,140.0,7.449219,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
64.98798,female,0.0,Lung Cancer,12.0,under $11k,8137.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1987305
80.62097,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,104163.0,white,135.0,7.129883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3618164
72.172,male,1.0,Lung Cancer,12.0,under $11k,62158.0,white,135.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
53.06198,male,0.0,COPD,12.0,under $11k,6734.0,white,126.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6191406
52.50699,female,1.0,CHF,12.0,$11-$25k,20735.0,white,129.0,7.419922,135.0,23.0,1968.0,6.0,7.0,<2 mo. follow-up,7.0
74.97095,male,0.0,Colon Cancer,12.0,under $11k,43009.0,white,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9162598
53.34998,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,483991.0,asian,154.0,7.369141,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
89.58795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19238.0,white,130.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.5683594
56.62399,male,0.0,Colon Cancer,12.0,>$50k,27408.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.04199,male,0.0,Colon Cancer,16.0,under $11k,8723.0,hispanic,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.2495117
75.76196,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,74162.0,white,132.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
32.99899,female,1.0,Cirrhosis,19.0,$25-$50k,88720.0,other,127.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.39697,female,0.0,CHF,10.0,under $11k,11588.0,black,138.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.5,male,0.0,CHF,10.0,under $11k,29870.0,white,133.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
72.78296,male,0.0,CHF,13.0,under $11k,45798.0,white,139.0,7.519531,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
61.56897,female,0.0,CHF,8.0,under $11k,22040.0,white,134.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
52.43298,female,0.0,Colon Cancer,16.0,$11-$25k,12161.0,black,140.0,7.419922,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
66.93195,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88469.0,black,142.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
84.76697,female,0.0,COPD,16.0,under $11k,19608.0,white,138.0,7.429688,135.0,23.0,1968.0,1.0,7.0,adl>=4 (>=5 if sur),7.0
80.172,male,0.0,CHF,8.0,$11-$25k,6148.0,white,136.0,7.349609,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
79.96997,male,0.0,CHF,14.0,$11-$25k,17554.0,other,140.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.45599,male,0.0,CHF,16.0,under $11k,25668.0,white,129.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.116,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,33960.0,white,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7563477
67.49097,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,172597.0,white,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7509766
52.09,male,0.0,Cirrhosis,8.0,$11-$25k,13414.0,white,133.0,7.429688,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,1.0
66.59296,male,0.0,CHF,8.0,$11-$25k,5872.0,black,139.0,7.479492,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
56.13998,male,0.0,Cirrhosis,12.0,under $11k,6083.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0625
63.76199,male,0.0,Colon Cancer,12.0,under $11k,7737.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7080078
39.73199,male,0.0,CHF,12.0,under $11k,16616.0,black,137.0,7.419922,135.0,23.0,1968.0,6.0,4.0,no(M2 and SIP pres),4.0
60.40198,male,0.0,CHF,16.0,>$50k,9381.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.771,male,0.0,Colon Cancer,12.0,under $11k,25187.0,other,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0932617
48.07397,male,0.0,CHF,12.0,under $11k,5570.0,other,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3574219
76.68396,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,229314.0,black,138.0,7.509766,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
78.35699,male,0.0,CHF,12.0,under $11k,4629.0,black,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
85.29999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,20365.0,white,146.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9472656
62.47498,male,0.0,CHF,11.0,$11-$25k,68367.0,white,125.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
76.41296,female,0.0,CHF,6.0,under $11k,4386.0,black,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.3959961
45.11398,male,1.0,Lung Cancer,12.0,under $11k,13100.0,black,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7583008
68.12598,female,0.0,Cirrhosis,12.0,under $11k,6992.0,black,133.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2592773
82.17694,female,0.0,Lung Cancer,15.0,$25-$50k,15942.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
41.87,male,0.0,Cirrhosis,12.0,>$50k,68108.0,white,140.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.20795,female,0.0,Cirrhosis,11.0,under $11k,3644.0,black,124.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
60.04398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,506141.0,white,131.0,7.399414,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
77.13898,male,1.0,ARF/MOSF w/Sepsis,20.0,$11-$25k,159553.0,white,137.0,7.5,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
72.96399,female,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,42243.0,white,135.0,7.349609,135.0,23.0,1968.0,4.0,3.0,adl>=4 (>=5 if sur),3.0
59.40598,male,0.0,CHF,12.0,>$50k,19852.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
72.83795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,740010.0,white,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,2.8237305
50.23099,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44480.0,white,140.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4614258
71.56195,female,0.0,Colon Cancer,12.0,$25-$50k,15051.0,white,141.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
71.90399,male,0.0,Colon Cancer,10.0,under $11k,24612.0,hispanic,136.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
44.62997,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40418.0,white,140.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3632812
51.98398,female,0.0,Colon Cancer,17.0,>$50k,29303.0,white,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
53.82599,male,0.0,CHF,12.0,$25-$50k,24587.0,hispanic,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6064453
50.431,male,1.0,MOSF w/Malig,12.0,under $11k,70463.0,white,132.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1044922
31.69099,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,274531.0,hispanic,137.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.30896,female,0.0,COPD,12.0,under $11k,84901.0,white,136.0,7.469727,135.0,23.0,1968.0,0.0,1.0,SIP>=30,3.0009766
81.54095,male,0.0,CHF,12.0,$25-$50k,20850.0,white,139.0,7.449219,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
66.39795,male,0.0,CHF,16.0,under $11k,17247.0,white,134.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.20099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,218924.0,white,134.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5366211
88.29797,male,0.0,CHF,8.0,under $11k,63639.0,white,131.0,7.479492,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
58.41498,female,0.0,Colon Cancer,14.0,$25-$50k,58940.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5058594
56.34998,female,0.0,Lung Cancer,12.0,under $11k,26731.0,white,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6875
71.69897,female,0.0,Colon Cancer,19.0,under $11k,5319.0,white,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
32.13998,male,1.0,MOSF w/Malig,12.0,under $11k,256835.0,other,125.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2148438
48.10999,female,0.0,Cirrhosis,2.0,$11-$25k,56562.0,hispanic,131.0,7.419922,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
76.383,male,0.0,Colon Cancer,12.0,under $11k,24788.0,other,134.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.262207
57.81,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125797.0,white,144.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.76794,female,0.0,Colon Cancer,12.0,under $11k,15358.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
46.45898,male,0.0,Colon Cancer,16.0,>$50k,21906.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.34796,female,0.0,Colon Cancer,12.0,$11-$25k,77328.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.23596,female,0.0,Colon Cancer,12.0,$11-$25k,26189.0,asian,137.0,7.289062,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.60394,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,58853.0,white,136.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6474609
36.45999,female,0.0,Coma,12.0,under $11k,201322.0,white,139.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3637695
63.77298,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,89043.0,white,127.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4150391
65.70599,male,0.0,Colon Cancer,18.0,$25-$50k,8729.0,hispanic,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
20.83199,male,1.0,MOSF w/Malig,12.0,under $11k,392950.0,white,132.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.1416016
52.668,female,1.0,Coma,12.0,under $11k,104602.0,white,138.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5009766
75.36798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125256.0,white,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9306641
53.86697,male,0.0,CHF,18.0,under $11k,20923.0,white,139.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
44.35898,male,0.0,CHF,12.0,$11-$25k,12042.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4326172
53.62097,female,0.0,Cirrhosis,12.0,under $11k,279530.0,white,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4321289
84.90295,female,0.0,Colon Cancer,15.0,$11-$25k,9291.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.83899,male,0.0,CHF,12.0,under $11k,10955.0,white,133.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.1845703
70.06195,male,0.0,CHF,12.0,under $11k,15687.0,hispanic,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
37.71899,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,268805.0,white,148.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.45697,female,1.0,Lung Cancer,13.0,$11-$25k,41397.0,black,134.0,7.459961,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
29.88399,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,223581.0,white,135.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
87.521,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,469824.0,white,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3193359
18.146,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,641888.0,hispanic,134.0,7.349609,135.0,23.0,1968.0,0.0,0.0,Coma or Intub,0.0
42.92398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,277421.0,white,135.0,7.209961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0610352
37.396,female,1.0,Cirrhosis,13.0,$11-$25k,166927.0,black,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8491211
63.46899,male,0.0,Colon Cancer,12.0,under $11k,29732.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1762695
53.57999,female,0.0,COPD,12.0,under $11k,5132.0,white,136.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3583984
70.07495,male,0.0,CHF,11.0,$11-$25k,33290.0,black,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
47.633,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,138674.0,asian,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6940918
51.54797,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,170244.0,white,132.0,7.469727,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
90.83899,female,0.0,CHF,12.0,under $11k,14065.0,white,145.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8759766
35.625,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,23421.0,black,135.0,7.15918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0986328
63.85999,female,1.0,Coma,12.0,under $11k,47424.0,white,149.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5307617
67.04199,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,100735.0,white,138.0,7.489258,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
61.16098,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,970982.0,white,134.0,7.40918,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.8037109
77.13098,male,0.0,Lung Cancer,12.0,under $11k,29403.0,white,135.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9814453
19.14,male,0.0,CHF,12.0,$25-$50k,216359.0,white,125.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.18097,male,0.0,Colon Cancer,14.0,$11-$25k,26311.0,white,133.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
53.30298,female,0.0,Colon Cancer,12.0,under $11k,17823.0,white,138.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
55.28799,female,0.0,CHF,13.0,under $11k,19419.0,white,133.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1230469
53.14697,male,0.0,CHF,14.0,under $11k,16552.0,asian,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
32.44098,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,1273347.0,white,143.0,7.509766,135.0,23.0,1968.0,0.0,7.0,Coma or Intub,7.0
58.95999,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,207902.0,white,136.0,7.5,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
27.411,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,122322.0,white,137.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
77.09497,male,0.0,CHF,16.0,>$50k,23862.0,white,137.0,7.419922,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
63.69299,female,0.0,CHF,11.0,$11-$25k,46112.0,white,134.0,7.419922,135.0,23.0,1968.0,3.0,3.0,SIP>=30,3.0
62.185,female,0.0,Lung Cancer,12.0,under $11k,35575.0,black,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.390625
53.52197,female,0.0,COPD,12.0,$11-$25k,20893.0,white,139.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),4.2832031
23.39999,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,943804.0,hispanic,130.0,7.469727,135.0,23.0,1968.0,0.0,0.0,Coma or Intub,0.0
65.60999,female,0.0,CHF,12.0,under $11k,25467.0,white,122.0,7.479492,135.0,23.0,1968.0,0.0,2.0,SIP>=30,2.0
70.28094,male,1.0,Cirrhosis,12.0,under $11k,28159.0,white,129.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
60.71997,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,63858.0,white,138.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6665039
77.00494,female,0.0,CHF,12.0,under $11k,15565.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0146484
42.05298,male,0.0,CHF,12.0,$11-$25k,24897.0,hispanic,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.75,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,254366.0,asian,139.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5249023
71.28796,male,1.0,CHF,15.0,under $11k,4854.0,white,127.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
22.66899,female,0.0,CHF,15.0,under $11k,18751.0,hispanic,117.0,7.5,135.0,23.0,1968.0,4.0,1.0,adl>=4 (>=5 if sur),3.1831989
59.12399,female,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,43164.0,white,140.0,7.299805,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
63.896,male,0.0,Cirrhosis,12.0,>$50k,227392.0,hispanic,135.0,7.469727,135.0,23.0,1968.0,3.0,5.0,SIP>=30,5.0
87.43097,male,1.0,CHF,12.0,under $11k,89889.0,white,125.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5537109
78.89899,male,0.0,COPD,12.0,under $11k,40247.0,white,139.0,7.329102,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
83.64099,male,0.0,CHF,10.0,under $11k,25653.0,white,131.0,7.439453,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
47.737,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,592486.0,black,130.0,7.139648,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,1.0
78.84998,female,0.0,CHF,8.0,under $11k,9914.0,black,137.0,7.459961,135.0,23.0,1968.0,4.0,6.0,SIP>=30,6.0
51.18399,male,0.0,CHF,6.0,under $11k,22621.0,black,126.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
61.45398,male,0.0,Colon Cancer,30.0,>$50k,60175.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0556641
55.20297,male,0.0,CHF,15.0,under $11k,3035.0,other,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
74.06396,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44728.0,white,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.402832
90.90796,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,69364.0,white,137.0,7.399414,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
38.94897,male,1.0,Cirrhosis,9.0,$11-$25k,133918.0,hispanic,126.0,7.419922,135.0,23.0,1968.0,5.0,3.0,<2 mo. follow-up,3.0
65.14697,female,0.0,Lung Cancer,12.0,under $11k,5223.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4189453
51.62799,female,0.0,CHF,13.0,$25-$50k,23146.0,white,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
56.20499,male,0.0,Lung Cancer,12.0,under $11k,42041.0,white,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7797852
65.88599,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19662.0,white,139.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.237793
69.19598,male,0.0,CHF,14.0,$11-$25k,24859.0,asian,126.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.74695,male,0.0,Lung Cancer,12.0,under $11k,16325.0,other,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.09595,male,0.0,CHF,12.0,$11-$25k,5293.0,white,131.0,7.419922,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
71.54596,male,0.0,Lung Cancer,20.0,>$50k,23304.0,white,137.0,7.509766,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
60.61899,male,0.0,CHF,14.0,under $11k,49079.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
58.478,male,0.0,CHF,12.0,under $11k,3580.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6030273
52.67899,male,0.0,CHF,16.0,under $11k,17110.0,asian,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.48596,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149983.0,white,134.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6967773
50.58197,male,0.0,Cirrhosis,10.0,$25-$50k,9113.0,hispanic,128.0,7.489258,135.0,23.0,1968.0,4.0,1.0,Coma or Intub,3.1831989
25.487,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,126732.0,white,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3955078
88.69495,male,1.0,Coma,12.0,>$50k,24242.0,white,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.01898,male,0.0,MOSF w/Malig,12.0,under $11k,659433.0,white,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2172852
81.77698,female,0.0,Cirrhosis,7.0,under $11k,5405.0,black,138.0,7.419922,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
71.86298,male,0.0,CHF,12.0,under $11k,3869.0,white,138.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2963867
72.19696,female,0.0,CHF,12.0,under $11k,9991.0,black,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4404297
53.40997,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,102911.0,white,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5112305
34.35699,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,110596.0,hispanic,130.0,7.30957,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
56.66498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,206651.0,white,147.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3227539
53.67798,female,0.0,Cirrhosis,13.0,under $11k,14583.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.32898,male,0.0,Lung Cancer,12.0,$25-$50k,11985.0,asian,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.056,male,1.0,Coma,18.0,$25-$50k,46156.0,white,128.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
70.80396,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,222230.0,hispanic,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2109375
86.57098,female,1.0,Coma,12.0,under $11k,10662.0,white,133.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.831543
52.44897,male,0.0,Lung Cancer,12.0,under $11k,10469.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
50.97897,male,0.0,COPD,14.0,under $11k,27015.0,white,137.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
77.75995,male,1.0,CHF,14.0,under $11k,34038.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.18198,male,1.0,MOSF w/Malig,17.0,>$50k,40620.0,white,130.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
34.17398,female,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,39002.0,white,128.0,7.399414,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
80.52295,male,0.0,CHF,12.0,under $11k,5853.0,white,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6611328
50.53,male,0.0,CHF,13.0,under $11k,18574.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0595703
56.82397,female,0.0,COPD,12.0,under $11k,49730.0,black,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.105957
45.892,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,330735.0,black,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6865234
69.71698,female,1.0,Coma,12.0,under $11k,21696.0,white,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9838867
65.89996,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,143419.0,white,131.0,7.5,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
38.491,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,111543.0,white,134.0,7.259766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4545898
65.53595,male,0.0,MOSF w/Malig,27.0,>$50k,61126.0,black,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1010742
59.146,male,0.0,Lung Cancer,11.0,under $11k,17737.0,white,138.0,7.419922,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
53.922,female,0.0,Colon Cancer,16.0,$25-$50k,46135.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.050293
40.63199,male,0.0,CHF,1.0,$11-$25k,29551.0,hispanic,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.67596,male,0.0,Lung Cancer,12.0,under $11k,57969.0,white,132.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
53.10098,male,1.0,CHF,12.0,under $11k,15394.0,white,132.0,7.679688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8071289
43.28299,female,1.0,MOSF w/Malig,12.0,under $11k,100051.0,white,146.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5332031
35.14297,male,0.0,Lung Cancer,14.0,>$50k,7880.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
51.49899,female,0.0,Cirrhosis,12.0,under $11k,5765.0,white,130.0,7.549805,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
76.44897,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,92307.0,white,144.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
81.24597,female,1.0,Coma,12.0,under $11k,15473.0,white,135.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.2402344
19.60599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,413774.0,white,155.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1264648
63.431,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,409250.0,white,141.0,7.489258,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
52.37198,male,0.0,COPD,12.0,under $11k,6622.0,black,140.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
38.883,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,34680.0,hispanic,133.0,7.449219,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
77.67596,male,1.0,MOSF w/Malig,12.0,under $11k,26620.0,white,131.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7626953
75.96698,female,0.0,Lung Cancer,12.0,under $11k,12424.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.38699,female,1.0,MOSF w/Malig,12.0,under $11k,221026.0,white,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3369141
47.24698,female,0.0,Lung Cancer,16.0,under $11k,29076.0,asian,135.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9604492
69.66699,male,1.0,Cirrhosis,12.0,under $11k,122908.0,white,138.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5512695
57.58197,male,0.0,CHF,10.0,under $11k,26110.0,white,140.0,7.539062,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
50.64798,male,0.0,CHF,12.0,under $11k,23376.0,black,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.07898,male,0.0,Colon Cancer,12.0,>$50k,22300.0,white,142.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.47998,male,0.0,Colon Cancer,12.0,under $11k,11506.0,white,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2626953
62.875,male,0.0,Colon Cancer,14.0,>$50k,23575.0,white,137.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
74.10797,male,1.0,COPD,12.0,$11-$25k,73695.0,white,140.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
66.73199,male,0.0,Colon Cancer,16.0,$25-$50k,30052.0,white,140.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
71.39996,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,163714.0,white,143.0,7.469727,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
60.85699,female,0.0,Lung Cancer,12.0,under $11k,22052.0,white,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5507812
47.37598,female,1.0,MOSF w/Malig,12.0,$11-$25k,266998.0,white,145.0,7.379883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.15094,female,1.0,CHF,10.0,$11-$25k,27021.0,black,140.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
64.24597,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,32157.0,hispanic,143.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
21.63699,female,0.0,Colon Cancer,16.0,>$50k,17730.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.58899,male,1.0,Lung Cancer,12.0,>$50k,17989.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.20599,female,0.0,COPD,12.0,under $11k,28330.0,black,142.0,7.379883,135.0,23.0,1968.0,6.0,6.0,adl>=4 (>=5 if sur),6.0
66.54596,male,1.0,ARF/MOSF w/Sepsis,15.0,>$50k,348628.0,white,127.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9897461
66.66895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,922581.0,asian,148.0,7.489258,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,2.265625
73.36597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,536925.0,white,144.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1137695
37.59299,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29615.0,white,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9033203
61.34399,female,0.0,Colon Cancer,11.0,under $11k,30431.0,hispanic,140.0,7.379883,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
65.92499,male,0.0,Colon Cancer,16.0,>$50k,6228.0,asian,137.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
47.33197,female,0.0,COPD,12.0,under $11k,35296.0,white,133.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0380859
32.18298,female,0.0,CHF,12.0,under $11k,12924.0,white,134.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8623047
48.04398,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,786088.0,white,143.0,7.469727,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
71.66296,female,1.0,Coma,12.0,under $11k,21598.0,white,127.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2768555
64.45197,male,0.0,CHF,12.0,under $11k,30265.0,white,126.0,7.549805,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
24.515,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,83772.0,hispanic,140.0,7.5,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
74.034,female,1.0,Colon Cancer,12.0,under $11k,6429.0,white,127.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3735352
72.03296,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,61750.0,white,138.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8081055
68.60797,male,0.0,CHF,12.0,under $11k,8303.0,white,142.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9321289
59.40598,male,0.0,CHF,14.0,$11-$25k,157585.0,asian,132.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),1.0
20.312,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,99728.0,white,141.0,7.439453,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
80.19397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,29857.0,white,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9487305
42.06699,male,1.0,MOSF w/Malig,18.0,$11-$25k,137943.0,white,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2294922
23.81699,male,0.0,MOSF w/Malig,13.0,$25-$50k,245347.0,black,135.0,7.429688,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
65.97095,male,0.0,CHF,12.0,under $11k,16273.0,white,136.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4047852
67.00098,male,0.0,CHF,12.0,under $11k,15242.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1396484
58.09698,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,150445.0,hispanic,137.0,7.549805,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3178711
34.99799,female,0.0,Coma,18.0,>$50k,8265.0,white,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
65.96295,male,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,181645.0,hispanic,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.097168
43.85999,female,0.0,Cirrhosis,12.0,$11-$25k,186293.0,hispanic,138.0,7.469727,135.0,23.0,1968.0,7.0,3.0,<2 mo. follow-up,3.0
29.769,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,181539.0,asian,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1264648
52.71997,female,1.0,Cirrhosis,20.0,$11-$25k,45273.0,white,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0878906
26.24799,male,1.0,MOSF w/Malig,12.0,under $11k,260829.0,white,138.0,7.219727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0917969
66.75397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,306038.0,white,139.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
53.125,male,0.0,Lung Cancer,8.0,$11-$25k,13872.0,white,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.74097,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,72222.0,white,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4282227
54.67798,male,0.0,CHF,14.0,under $11k,38322.0,white,145.0,7.5,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
81.45398,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,92518.0,white,132.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4912109
58.27499,female,0.0,COPD,12.0,under $11k,161257.0,black,144.0,7.299805,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
36.96899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,85027.0,other,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4121094
44.47897,male,0.0,Cirrhosis,16.0,$25-$50k,12696.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.98096,male,0.0,Colon Cancer,16.0,>$50k,42514.0,white,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
82.245,female,1.0,Coma,12.0,under $11k,73656.0,white,140.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.355957
38.49698,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,463001.0,white,145.0,7.529297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.37598,male,0.0,MOSF w/Malig,12.0,under $11k,64372.0,black,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.44998,male,0.0,CHF,20.0,under $11k,30148.0,white,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
83.30194,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,49455.0,white,138.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5644531
43.995,female,0.0,Cirrhosis,12.0,$11-$25k,260514.0,white,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
50.09698,male,0.0,MOSF w/Malig,12.0,under $11k,29840.0,other,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
80.18896,male,1.0,ARF/MOSF w/Sepsis,19.0,>$50k,257589.0,white,147.0,7.469727,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
40.20499,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,151181.0,white,143.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0107422
57.01797,female,0.0,CHF,12.0,under $11k,12504.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4633789
38.90799,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,48336.0,white,125.0,7.289062,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
75.54297,male,0.0,Colon Cancer,14.0,$25-$50k,18233.0,white,136.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
34.80899,female,1.0,MOSF w/Malig,12.0,under $11k,71315.0,white,141.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0834961
73.72998,male,0.0,Colon Cancer,12.0,under $11k,41836.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1674805
42.543,male,1.0,MOSF w/Malig,12.0,under $11k,217970.0,white,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6279297
68.70099,male,0.0,Lung Cancer,12.0,under $11k,8570.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2436523
73.56299,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,192983.0,white,132.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9082031
69.10297,female,0.0,Colon Cancer,12.0,under $11k,39080.0,white,145.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4438477
67.41095,male,1.0,Coma,12.0,under $11k,19247.0,white,151.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9233398
79.72095,male,1.0,CHF,18.0,>$50k,23327.0,asian,129.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
48.35898,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,60676.0,hispanic,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.67398,male,1.0,CHF,12.0,>$50k,481475.0,white,125.0,7.529297,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
58.31897,female,0.0,Cirrhosis,12.0,under $11k,5877.0,hispanic,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1245117
59.88498,male,0.0,CHF,14.0,$25-$50k,25441.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.02698,male,0.0,CHF,12.0,under $11k,11926.0,white,136.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6655273
34.461,female,1.0,MOSF w/Malig,12.0,under $11k,193371.0,white,141.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9511719
47.33499,female,0.0,Colon Cancer,12.0,under $11k,53037.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6083984
47.77798,female,0.0,Cirrhosis,12.0,under $11k,14867.0,other,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1303711
49.28998,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,73143.0,white,139.0,7.069336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1860352
51.573,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,121630.0,white,133.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3798828
73.90295,male,0.0,CHF,16.0,under $11k,6676.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2524414
71.28497,male,0.0,Lung Cancer,12.0,under $11k,16142.0,white,137.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5341797
55.29898,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,85170.0,white,130.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8974609
52.68997,male,0.0,MOSF w/Malig,12.0,under $11k,50315.0,white,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7290039
81.38794,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,207883.0,white,138.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1708984
49.29999,male,0.0,Cirrhosis,12.0,under $11k,241565.0,white,148.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9243164
64.69299,male,0.0,Colon Cancer,12.0,$25-$50k,24410.0,white,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
61.67798,male,0.0,Colon Cancer,12.0,>$50k,18565.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5693359
64.25195,male,0.0,CHF,6.0,under $11k,7339.0,white,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1958008
56.95798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,80188.0,other,146.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5454102
29.71399,male,1.0,MOSF w/Malig,12.0,under $11k,55429.0,other,128.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3691406
35.56998,female,0.0,MOSF w/Malig,19.0,>$50k,141926.0,black,133.0,7.459961,135.0,23.0,1968.0,5.0,6.0,<2 mo. follow-up,6.0
38.42297,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,36468.0,black,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4711914
62.53497,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,188728.0,white,148.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7363281
76.49597,male,1.0,Lung Cancer,12.0,under $11k,7422.0,white,146.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1860352
83.16199,male,1.0,Coma,12.0,under $11k,13767.0,white,136.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2773438
57.52798,male,0.0,Coma,12.0,under $11k,82244.0,white,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3989258
73.66498,male,0.0,Colon Cancer,12.0,under $11k,9640.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
46.51099,male,0.0,Cirrhosis,15.0,$25-$50k,603388.0,black,137.0,7.629883,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
78.91895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,219537.0,white,140.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2841797
68.91394,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30869.0,white,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.762207
42.29199,female,1.0,MOSF w/Malig,12.0,under $11k,161776.0,white,125.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1401367
46.57898,male,0.0,CHF,22.0,under $11k,17254.0,black,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
54.03998,male,0.0,CHF,16.0,>$50k,135849.0,white,129.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
45.10599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35204.0,white,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7602539
87.46295,female,0.0,CHF,12.0,>$50k,12163.0,white,126.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.7792969
79.24695,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,174898.0,black,135.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.73999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,352017.0,other,146.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2241211
78.17395,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,372459.0,asian,131.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9794922
79.13196,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,36811.0,white,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6357422
70.63898,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,104045.0,white,139.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
41.26498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,597427.0,white,151.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.331543
38.35699,female,0.0,Colon Cancer,12.0,under $11k,5573.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0043945
59.92099,male,0.0,Lung Cancer,12.0,under $11k,19491.0,black,130.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5507812
58.11899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40421.0,white,127.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1513672
35.25,female,0.0,MOSF w/Malig,12.0,under $11k,271731.0,white,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2861328
66.18994,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,53786.0,white,143.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
41.02698,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,237244.0,white,141.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1860352
54.93198,male,0.0,Cirrhosis,12.0,under $11k,25024.0,white,145.0,7.55957,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9755859
78.58997,male,1.0,Colon Cancer,12.0,under $11k,5871.0,black,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1899414
82.21497,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,135785.0,white,143.0,7.509766,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
40.34198,male,1.0,MOSF w/Malig,16.0,>$50k,370093.0,white,139.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.84097,male,1.0,CHF,16.0,under $11k,173498.0,white,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7094727
67.82996,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,242746.0,white,145.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4858398
65.41296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,86956.0,black,133.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5546875
74.297,male,0.0,CHF,18.0,>$50k,19565.0,white,134.0,7.169922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
61.78799,female,0.0,Lung Cancer,12.0,under $11k,4226.0,black,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5039062
45.43198,male,1.0,MOSF w/Malig,16.0,$11-$25k,110902.0,hispanic,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4604492
62.45297,male,0.0,CHF,16.0,>$50k,269517.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.28094,male,0.0,Colon Cancer,12.0,under $11k,25535.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3105469
52.28497,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,303548.0,white,141.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
57.76599,male,0.0,CHF,12.0,under $11k,30477.0,black,136.0,7.55957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3032227
54.74298,male,1.0,MOSF w/Malig,12.0,under $11k,79089.0,white,128.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3017578
54.78198,male,0.0,Lung Cancer,12.0,under $11k,7383.0,black,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
46.69998,female,1.0,MOSF w/Malig,12.0,under $11k,105684.0,other,132.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8427734
36.59097,male,1.0,MOSF w/Malig,12.0,under $11k,80565.0,white,128.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6972656
83.39496,male,0.0,CHF,13.0,$11-$25k,3968.0,black,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
41.29797,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,182264.0,black,128.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
90.13794,male,0.0,MOSF w/Malig,24.0,under $11k,124700.0,white,138.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.7294922
20.09599,female,0.0,CHF,12.0,$11-$25k,51152.0,black,130.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
38.92999,male,0.0,Cirrhosis,14.0,$25-$50k,4117.0,white,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
39.81897,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,79944.0,white,138.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0444336
53.09497,female,1.0,Cirrhosis,12.0,under $11k,47800.0,white,137.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5976562
53.38498,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,81459.0,white,128.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7265625
79.81396,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,98268.0,white,144.0,7.30957,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.371582
68.45996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26493.0,black,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.9082031
52.52597,female,0.0,CHF,16.0,$11-$25k,20605.0,black,136.0,7.339844,135.0,23.0,1968.0,6.0,3.0,adl>=4 (>=5 if sur),3.0
62.50198,male,0.0,CHF,4.0,$11-$25k,8761.0,hispanic,138.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5043945
57.02899,male,0.0,Cirrhosis,17.0,$11-$25k,145874.0,white,136.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.448,male,0.0,CHF,3.0,under $11k,13444.0,black,139.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
87.76697,female,0.0,COPD,16.0,under $11k,109552.0,white,143.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4589844
65.71399,male,1.0,Coma,12.0,under $11k,45707.0,white,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.753418
46.97098,female,0.0,COPD,9.0,under $11k,5975.0,hispanic,139.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
62.10797,male,0.0,CHF,7.0,under $11k,22091.0,white,138.0,7.419922,135.0,23.0,1968.0,2.0,5.0,SIP>=30,5.0
81.99896,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,117689.0,white,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9467773
62.53,female,0.0,Colon Cancer,12.0,under $11k,16862.0,white,134.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.52197,female,0.0,CHF,13.0,>$50k,414803.0,white,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
49.87,male,1.0,MOSF w/Malig,12.0,under $11k,59913.0,white,133.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2265625
61.69199,female,0.0,Colon Cancer,12.0,$11-$25k,75618.0,white,141.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),4.5273972
39.14899,female,0.0,CHF,12.0,$25-$50k,147711.0,black,130.0,7.419922,135.0,23.0,1968.0,5.0,4.0,<2 mo. follow-up,4.0
50.45599,female,1.0,MOSF w/Malig,12.0,under $11k,202111.0,white,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5595703
50.57599,female,0.0,Cirrhosis,10.0,under $11k,303934.0,white,147.0,7.229492,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
68.80798,female,0.0,CHF,14.0,under $11k,7354.0,black,128.0,7.459961,135.0,23.0,1968.0,4.0,1.0,SIP>=30,3.1831989
46.07797,male,0.0,Cirrhosis,18.0,>$50k,353422.0,white,147.0,7.589844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.16498,female,0.0,CHF,12.0,under $11k,3974.0,white,141.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2495117
81.758,female,0.0,CHF,8.0,under $11k,22800.0,white,128.0,7.519531,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
76.98798,female,0.0,COPD,16.0,under $11k,113045.0,white,134.0,7.40918,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
81.66498,female,1.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,31827.0,white,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6464844
54.26999,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,44608.0,white,138.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
22.825,male,1.0,MOSF w/Malig,12.0,under $11k,254601.0,white,139.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9663086
58.43698,female,0.0,Colon Cancer,20.0,>$50k,14670.0,white,135.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
58.28598,male,0.0,Colon Cancer,14.0,>$50k,24073.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
84.29297,female,0.0,CHF,12.0,under $11k,5110.0,white,137.0,7.609375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0571289
47.01999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,56169.0,white,149.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.171875
42.28897,female,0.0,Cirrhosis,15.0,$11-$25k,6057.0,white,133.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
86.37097,male,0.0,CHF,12.0,under $11k,14836.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.03125
72.23499,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,23972.0,white,157.0,7.439453,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
85.35199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,239683.0,white,137.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
49.13898,female,0.0,Lung Cancer,12.0,under $11k,17775.0,black,129.0,7.419922,135.0,23.0,1968.0,3.0,5.0,adl>=4 (>=5 if sur),5.0
79.04395,female,1.0,COPD,12.0,under $11k,36520.0,white,139.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4482422
41.61798,male,1.0,MOSF w/Malig,12.0,under $11k,161755.0,white,149.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9682617
25.49199,female,1.0,MOSF w/Malig,12.0,under $11k,359124.0,white,125.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6630859
50.754,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,448431.0,white,131.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8657227
53.09198,female,0.0,Cirrhosis,12.0,>$50k,13434.0,white,124.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
75.80798,male,0.0,Lung Cancer,3.0,>$50k,73798.0,white,143.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
75.99695,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,99364.0,white,134.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.491,male,0.0,Cirrhosis,12.0,under $11k,9974.0,white,125.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3310547
27.51799,female,1.0,MOSF w/Malig,12.0,under $11k,132130.0,hispanic,136.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.62198,male,0.0,Lung Cancer,12.0,>$50k,11765.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.12695,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,107073.0,white,141.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
30.023,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,108131.0,white,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0869141
52.70099,female,0.0,Lung Cancer,14.0,$25-$50k,6521.0,white,140.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
52.767,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,45767.0,black,145.0,7.449219,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
50.38199,female,0.0,CHF,11.0,under $11k,25748.0,black,138.0,7.419922,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
37.336,female,1.0,MOSF w/Malig,12.0,under $11k,168270.0,other,145.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4541016
65.57697,male,0.0,CHF,16.0,under $11k,42780.0,white,142.0,7.529297,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.29398,male,1.0,Cirrhosis,12.0,under $11k,49389.0,white,134.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9550781
55.31799,female,0.0,Cirrhosis,12.0,$11-$25k,16717.0,white,121.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
51.89899,female,1.0,MOSF w/Malig,12.0,under $11k,85777.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7719727
48.98599,male,1.0,Cirrhosis,12.0,under $11k,131400.0,white,138.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5107422
76.33398,male,0.0,CHF,7.0,under $11k,24988.0,white,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
24.493,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149776.0,white,132.0,7.449219,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
70.46698,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,57539.0,other,128.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.690918
58.31897,male,0.0,MOSF w/Malig,23.0,under $11k,542326.0,white,137.0,7.279297,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.6416016
80.25494,female,1.0,Coma,12.0,under $11k,14297.0,white,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5532227
67.58398,male,0.0,Lung Cancer,12.0,$11-$25k,10819.0,black,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7944336
40.96399,male,1.0,Cirrhosis,16.0,$11-$25k,93417.0,hispanic,136.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1333008
26.683,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,109747.0,other,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.85397,female,1.0,MOSF w/Malig,11.0,under $11k,173968.0,white,134.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4663086
77.53595,male,1.0,Coma,12.0,under $11k,20078.0,white,138.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9956055
70.03998,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,444556.0,white,132.0,7.269531,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
66.00098,male,0.0,CHF,12.0,$25-$50k,31463.0,white,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
59.995,female,0.0,COPD,8.0,under $11k,41479.0,hispanic,133.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
49.91599,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,220490.0,black,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3061523
51.56699,female,0.0,Cirrhosis,12.0,under $11k,1435423.0,other,126.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
55.13998,female,0.0,COPD,12.0,under $11k,7322.0,white,136.0,7.439453,135.0,23.0,1968.0,1.0,5.0,adl>=4 (>=5 if sur),5.0
30.69099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,138003.0,white,135.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5795898
47.34799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23807.0,white,143.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4794922
60.23297,male,0.0,Lung Cancer,12.0,under $11k,16410.0,other,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3388672
37.08099,male,0.0,Cirrhosis,12.0,under $11k,7547.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2421875
63.25,male,0.0,Lung Cancer,13.0,$25-$50k,15400.0,asian,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8708496
51.87698,male,0.0,Lung Cancer,16.0,>$50k,22975.0,white,133.0,7.519531,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.50299,male,0.0,CHF,12.0,under $11k,45162.0,white,127.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
84.43799,male,0.0,CHF,12.0,under $11k,25793.0,white,131.0,7.589844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6225586
46.60397,male,0.0,Lung Cancer,16.0,>$50k,17707.0,white,135.0,7.419922,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
60.07397,female,1.0,Lung Cancer,12.0,under $11k,6149.0,white,144.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4169922
62.27197,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,150556.0,white,132.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
48.353,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,565876.0,white,149.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8876953
78.33795,male,1.0,Coma,12.0,under $11k,31356.0,white,128.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2514648
58.14099,female,0.0,CHF,12.0,under $11k,4642.0,white,140.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5004883
60.87299,female,0.0,CHF,12.0,under $11k,29509.0,black,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.6489258
51.62198,male,1.0,MOSF w/Malig,10.0,under $11k,85043.0,black,133.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7714844
48.62399,female,0.0,MOSF w/Malig,16.0,$11-$25k,95852.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
29.63699,male,0.0,Coma,12.0,under $11k,168489.0,hispanic,135.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.146,male,0.0,Colon Cancer,16.0,>$50k,44109.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1723633
68.16998,female,0.0,Cirrhosis,12.0,under $11k,38996.0,white,137.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.621582
47.73398,male,0.0,CHF,15.0,under $11k,30953.0,black,126.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),4.5273972
91.84399,female,1.0,Coma,12.0,under $11k,11415.0,white,143.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0322266
59.39798,male,0.0,Colon Cancer,16.0,$25-$50k,8512.0,white,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
49.59598,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,102876.0,white,143.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.527832
51.086,female,0.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,480519.0,hispanic,150.0,7.519531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
46.22598,male,0.0,CHF,12.0,under $11k,349052.0,hispanic,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.77197,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,92775.0,white,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2773438
50.59497,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,93265.0,hispanic,134.0,7.079102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.1542969
60.56897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,75752.0,white,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6948242
43.21399,female,1.0,MOSF w/Malig,12.0,under $11k,43810.0,white,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7348633
82.63098,male,0.0,CHF,16.0,under $11k,7920.0,white,132.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
80.23798,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,43960.0,white,136.0,7.459961,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
26.023,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,166772.0,hispanic,130.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
22.72699,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,23778.0,black,134.0,7.469727,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
52.67599,male,0.0,Lung Cancer,17.0,>$50k,22661.0,white,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.11798,female,0.0,Lung Cancer,12.0,under $11k,12023.0,black,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8193359
36.211,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,374053.0,black,142.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.503418
29.588,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,563075.0,black,137.0,7.389648,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.7104492
63.95599,male,1.0,CHF,9.0,>$50k,68631.0,hispanic,125.0,7.419922,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
70.90997,male,1.0,CHF,18.0,under $11k,13400.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.63098,female,0.0,Cirrhosis,10.0,>$50k,14175.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2807617
77.17499,female,0.0,Cirrhosis,12.0,under $11k,14976.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.434082
60.54498,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,283844.0,hispanic,143.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7592773
76.56696,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,308455.0,white,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4482422
76.63495,male,0.0,CHF,11.0,$11-$25k,63938.0,white,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
51.20099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,41580.0,asian,133.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6914062
20.24399,male,0.0,CHF,12.0,under $11k,11528.0,hispanic,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8491211
69.47296,female,0.0,Cirrhosis,12.0,>$50k,151788.0,white,126.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.76099,female,1.0,Lung Cancer,12.0,under $11k,18406.0,white,130.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.887207
24.56699,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,392270.0,hispanic,137.0,7.369141,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
53.62097,female,0.0,Colon Cancer,12.0,under $11k,28094.0,white,140.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5981445
78.88794,male,1.0,MOSF w/Malig,13.0,>$50k,88377.0,white,147.0,7.5,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
68.40497,female,0.0,Lung Cancer,12.0,under $11k,32994.0,white,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
74.94299,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,345855.0,black,131.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6743164
72.98798,female,1.0,Coma,12.0,under $11k,16404.0,asian,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2197266
50.28897,female,0.0,Colon Cancer,12.0,under $11k,6673.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.871582
87.48297,female,0.0,CHF,12.0,under $11k,4969.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8491211
25.95799,male,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,73645.0,white,129.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4125977
78.88794,female,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,198860.0,white,128.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5380859
52.30099,male,0.0,Colon Cancer,12.0,under $11k,4510.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.5620117
49.08698,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,176752.0,white,142.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0224609
54.48599,female,0.0,Colon Cancer,15.0,under $11k,37609.0,white,133.0,7.329102,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
32.70599,female,1.0,ARF/MOSF w/Sepsis,21.0,under $11k,1233213.0,white,149.0,7.449219,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
40.46799,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,289233.0,white,135.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
76.47095,male,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,203430.0,asian,153.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0458984
64.20496,female,1.0,Cirrhosis,12.0,>$50k,103876.0,hispanic,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
56.07397,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,131009.0,white,149.0,7.399414,135.0,23.0,1968.0,0.0,4.0,SIP>=30,4.0
73.01794,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,57560.0,hispanic,120.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.50195,female,0.0,Colon Cancer,12.0,$11-$25k,14005.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.77594,female,0.0,Colon Cancer,12.0,under $11k,46753.0,white,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3530273
52.30698,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,54390.0,black,132.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.17099,female,0.0,Lung Cancer,12.0,>$50k,13399.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
47.18997,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,160900.0,other,148.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7456055
55.25497,female,1.0,Lung Cancer,12.0,under $11k,13593.0,black,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0058594
59.36798,male,0.0,CHF,12.0,>$50k,15494.0,white,131.0,7.549805,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
63.22498,male,0.0,Colon Cancer,12.0,under $11k,34247.0,white,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1767578
54.69699,male,1.0,MOSF w/Malig,18.0,>$50k,168940.0,white,151.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4682617
75.66095,male,0.0,CHF,12.0,under $11k,16067.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.421875
65.09198,female,0.0,Colon Cancer,12.0,>$50k,56695.0,white,139.0,7.359375,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
60.55298,male,0.0,Lung Cancer,12.0,under $11k,5619.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7854004
30.015,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,871855.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
35.92899,male,1.0,Colon Cancer,12.0,under $11k,39582.0,white,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.546875
54.84998,female,0.0,Lung Cancer,16.0,$11-$25k,3278.0,black,136.0,7.419922,135.0,23.0,1968.0,3.0,1.0,SIP>=30,1.0
90.32196,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,106419.0,white,133.0,7.459961,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
84.33899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,271224.0,white,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4804688
57.23999,male,0.0,Cirrhosis,19.0,>$50k,410745.0,white,150.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.9970703
38.80399,female,0.0,CHF,14.0,$25-$50k,133255.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
72.46497,female,0.0,Lung Cancer,12.0,under $11k,5552.0,black,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6166992
92.60199,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,50810.0,white,141.0,7.429688,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
59.69299,female,1.0,MOSF w/Malig,12.0,under $11k,71936.0,white,155.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4375
52.767,male,0.0,Cirrhosis,12.0,>$50k,43499.0,white,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.97098,female,0.0,COPD,8.0,>$50k,4936.0,black,135.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
62.35699,male,0.0,Coma,12.0,under $11k,58097.0,white,146.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0390625
82.01196,female,0.0,COPD,11.0,$11-$25k,45384.0,white,153.0,7.369141,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
53.46997,female,0.0,CHF,9.0,under $11k,23440.0,white,140.0,7.439453,135.0,23.0,1968.0,2.0,3.0,no(M2 and SIP pres),3.0
21.092,male,1.0,Coma,12.0,>$50k,91295.0,white,150.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5375977
19.866,female,0.0,CHF,11.0,under $11k,120028.0,black,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.10999,female,0.0,ARF/MOSF w/Sepsis,21.0,under $11k,546390.0,white,132.0,7.40918,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
69.66498,male,0.0,Lung Cancer,6.0,under $11k,9574.0,black,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
66.409,female,0.0,CHF,14.0,>$50k,43722.0,white,131.0,7.419922,135.0,23.0,1968.0,5.0,4.0,no(M2 and SIP pres),4.0
39.84698,female,0.0,MOSF w/Malig,12.0,under $11k,47588.0,white,111.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.7070312
66.14099,male,1.0,COPD,16.0,>$50k,21075.0,white,137.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0595703
53.24597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,231587.0,white,142.0,7.40918,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
69.94098,male,0.0,CHF,18.0,>$50k,5631.0,white,138.0,7.539062,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
20.69299,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,125185.0,white,134.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.78598,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,96189.0,white,153.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5883789
35.047,male,1.0,MOSF w/Malig,12.0,under $11k,155711.0,other,139.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3032227
72.01398,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,173394.0,white,133.0,7.55957,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
42.823,female,1.0,MOSF w/Malig,15.0,under $11k,393995.0,white,149.0,7.329102,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,1.0
63.84097,female,0.0,Colon Cancer,14.0,$25-$50k,13525.0,white,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6625977
62.59497,female,0.0,Cirrhosis,12.0,$11-$25k,30117.0,white,132.0,7.519531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
70.823,female,0.0,CHF,14.0,under $11k,51017.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
60.758,female,0.0,Colon Cancer,10.0,$25-$50k,24158.0,white,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5664062
76.03296,male,0.0,Colon Cancer,17.0,$25-$50k,14594.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.42599,male,0.0,Lung Cancer,12.0,under $11k,9366.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
58.58197,male,0.0,Cirrhosis,8.0,$11-$25k,44079.0,black,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.112793
38.155,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,143906.0,white,131.0,7.379883,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
79.97797,female,1.0,ARF/MOSF w/Sepsis,15.0,under $11k,214894.0,white,129.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.71497,female,0.0,CHF,14.0,$11-$25k,76132.0,black,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
65.53894,female,0.0,Lung Cancer,14.0,$25-$50k,7769.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.439,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,16863.0,black,130.0,7.489258,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
61.02698,male,0.0,Colon Cancer,13.0,under $11k,31943.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
66.37097,male,0.0,CHF,12.0,$25-$50k,50099.0,white,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.08899,female,1.0,Lung Cancer,12.0,$11-$25k,23806.0,white,138.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.26398,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,444915.0,white,142.0,7.269531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
31.72099,male,0.0,MOSF w/Malig,20.0,under $11k,58405.0,white,134.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.01099,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,50808.0,white,148.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0786133
83.59497,male,0.0,ARF/MOSF w/Sepsis,19.0,>$50k,81350.0,white,133.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
43.64697,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,528848.0,white,127.0,7.399414,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7421875
38.12198,female,0.0,Lung Cancer,12.0,under $11k,8624.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1303711
79.07495,female,0.0,CHF,7.0,under $11k,24141.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
84.91199,male,1.0,Cirrhosis,16.0,>$50k,30383.0,white,129.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.0
74.64795,male,1.0,Coma,8.0,under $11k,34042.0,white,135.0,7.469727,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
56.271,male,0.0,Lung Cancer,16.0,under $11k,15227.0,white,134.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3735352
75.23096,male,0.0,CHF,20.0,$25-$50k,29545.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
40.53098,female,0.0,Colon Cancer,11.0,>$50k,26039.0,hispanic,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2045898
74.40094,male,1.0,CHF,15.0,>$50k,22733.0,white,139.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5600586
77.67596,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,25024.0,black,134.0,7.449219,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
68.24597,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,162892.0,asian,131.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1791992
38.32999,male,0.0,Cirrhosis,12.0,under $11k,6062.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1689453
48.36697,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,74504.0,white,141.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2773438
80.87598,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,147296.0,white,135.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.38699,male,0.0,Lung Cancer,12.0,under $11k,7253.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3168945
60.03598,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,142731.0,white,137.0,7.569336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7958984
71.45197,female,0.0,COPD,10.0,under $11k,29501.0,white,125.0,7.299805,135.0,23.0,1968.0,0.0,6.0,no(M2 and SIP pres),6.0
32.95297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,42572.0,white,151.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1787109
39.63898,male,0.0,Cirrhosis,13.0,under $11k,272602.0,white,122.0,7.30957,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
85.11694,male,0.0,CHF,8.0,$11-$25k,15112.0,white,128.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
68.87299,female,1.0,Lung Cancer,18.0,under $11k,9982.0,white,138.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4711914
77.13599,male,1.0,Cirrhosis,19.0,$11-$25k,42561.0,white,134.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3701172
61.99597,male,0.0,CHF,12.0,under $11k,26184.0,white,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
50.97598,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,93205.0,white,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
53.45898,female,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,1057324.0,white,137.0,7.469727,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
70.93994,male,0.0,CHF,12.0,under $11k,20186.0,asian,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
89.77399,male,0.0,CHF,8.0,under $11k,5897.0,white,136.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
81.67596,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125968.0,white,135.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7275391
59.10199,male,0.0,CHF,7.0,$25-$50k,34775.0,hispanic,134.0,7.419922,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
56.64099,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,20497.0,white,140.0,7.379883,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
67.37,female,0.0,Cirrhosis,12.0,under $11k,50138.0,white,140.0,7.419922,135.0,23.0,1968.0,5.0,1.0,adl>=4 (>=5 if sur),3.855299
57.46698,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,150471.0,asian,141.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2636719
68.87897,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,65136.0,black,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7280273
35.806,female,0.0,CHF,12.0,under $11k,20092.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1542969
35.603,male,0.0,Colon Cancer,12.0,under $11k,41788.0,white,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9345703
43.47699,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,79576.0,hispanic,130.0,7.589844,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.68597,male,0.0,CHF,14.0,under $11k,16964.0,white,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
44.60797,female,1.0,Cirrhosis,8.0,under $11k,214817.0,hispanic,137.0,7.489258,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
70.04797,male,0.0,Cirrhosis,14.0,$25-$50k,26738.0,white,135.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
45.043,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,194716.0,white,148.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
60.79398,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,141714.0,white,137.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.88199,female,0.0,Lung Cancer,14.0,under $11k,6593.0,black,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2241211
65.02899,female,0.0,CHF,12.0,under $11k,3087.0,black,126.0,7.5,135.0,23.0,1968.0,2.0,6.0,<2 mo. follow-up,6.0
19.17,female,0.0,CHF,12.0,under $11k,166750.0,hispanic,131.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.340332
72.84296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,196869.0,white,127.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.65625
42.03699,male,1.0,Cirrhosis,20.0,>$50k,100295.0,white,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.806,female,0.0,COPD,14.0,$25-$50k,75895.0,asian,143.0,7.349609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.56097,male,1.0,Coma,16.0,>$50k,245849.0,black,129.0,7.539062,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
51.93997,male,0.0,MOSF w/Malig,12.0,under $11k,280893.0,white,140.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.24698,female,0.0,CHF,11.0,under $11k,6536.0,white,140.0,7.509766,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
73.75494,male,0.0,MOSF w/Malig,12.0,under $11k,29426.0,black,153.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8896484
47.93198,female,1.0,MOSF w/Malig,12.0,under $11k,92238.0,white,129.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2519531
58.69699,female,0.0,CHF,12.0,$11-$25k,6849.0,hispanic,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.371582
60.73099,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,363112.0,hispanic,142.0,7.469727,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
68.50397,male,0.0,MOSF w/Malig,16.0,>$50k,41674.0,white,131.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
41.75497,female,1.0,Coma,16.0,>$50k,69323.0,white,146.0,7.599609,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
48.14798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23166.0,white,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1948242
48.564,male,0.0,MOSF w/Malig,19.0,under $11k,225659.0,white,131.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
45.51398,male,1.0,Cirrhosis,16.0,>$50k,323371.0,asian,126.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
82.66699,female,0.0,Coma,12.0,under $11k,130916.0,white,125.0,7.519531,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
42.45599,male,0.0,ARF/MOSF w/Sepsis,10.0,>$50k,63445.0,hispanic,137.0,7.469727,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
70.20898,male,0.0,Lung Cancer,16.0,>$50k,9088.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
40.39999,male,0.0,Lung Cancer,12.0,under $11k,12693.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.730957
76.08997,male,0.0,CHF,8.0,under $11k,12254.0,white,142.0,7.449219,135.0,23.0,1968.0,6.0,1.0,<2 mo. follow-up,4.5273972
77.85895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,89858.0,white,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6572266
71.02295,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,132772.0,white,137.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4824219
30.35999,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,283773.0,black,136.0,7.389648,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
76.74194,male,0.0,CHF,12.0,under $11k,14066.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9550781
76.97198,female,0.0,CHF,13.0,>$50k,11489.0,black,139.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.745,female,0.0,CHF,16.0,$11-$25k,9478.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.5449219
65.93298,female,0.0,CHF,13.0,under $11k,10227.0,asian,141.0,7.459961,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
69.98199,female,0.0,CHF,12.0,under $11k,65732.0,black,130.0,7.389648,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
82.14099,male,0.0,MOSF w/Malig,12.0,under $11k,113460.0,black,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4794922
41.06198,female,0.0,ARF/MOSF w/Sepsis,15.0,$11-$25k,16536.0,black,130.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0395508
56.34998,female,0.0,COPD,12.0,under $11k,4944.0,white,130.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
67.72894,male,0.0,CHF,18.0,$11-$25k,32258.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9853516
51.18698,male,0.0,Colon Cancer,12.0,under $11k,30006.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5170898
48.43799,male,1.0,MOSF w/Malig,15.0,>$50k,275297.0,white,150.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2446289
63.573,female,1.0,MOSF w/Malig,12.0,$25-$50k,231839.0,white,125.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2402344
56.74197,male,0.0,Colon Cancer,18.0,$11-$25k,41129.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.43799,male,0.0,CHF,12.0,$11-$25k,73122.0,white,134.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.59094,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,white,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7763672
56.50098,male,1.0,Cirrhosis,12.0,under $11k,95243.0,white,137.0,7.439453,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
45.22699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,213989.0,white,132.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4370117
54.44498,male,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,61442.0,white,131.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5195312
85.36096,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,51486.0,white,131.0,7.229492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
46.08099,male,0.0,CHF,14.0,under $11k,170570.0,hispanic,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
32.42697,female,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,382471.0,white,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0322266
66.27496,male,0.0,Colon Cancer,20.0,>$50k,18606.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
78.53796,female,0.0,COPD,16.0,$25-$50k,8697.0,white,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.95099,female,1.0,MOSF w/Malig,12.0,under $11k,449923.0,black,144.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.81897,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,54871.0,white,132.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3813477
31.34299,female,1.0,Coma,12.0,under $11k,148727.0,white,132.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6069336
73.14697,male,0.0,CHF,4.0,>$50k,20810.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
73.70294,male,0.0,CHF,24.0,under $11k,14284.0,white,137.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
71.75397,female,0.0,COPD,9.0,under $11k,135615.0,black,137.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8969727
63.59799,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,51942.0,white,129.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.206543
72.323,male,0.0,Colon Cancer,12.0,under $11k,36244.0,white,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3491211
44.12299,female,0.0,MOSF w/Malig,12.0,under $11k,293158.0,white,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
21.74899,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,156314.0,white,145.0,7.30957,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.85797,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,234034.0,white,144.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.05099,female,0.0,Lung Cancer,12.0,under $11k,9864.0,black,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5302734
57.84799,male,1.0,MOSF w/Malig,14.0,$25-$50k,139623.0,white,152.0,7.289062,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
72.56097,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,301990.0,white,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
49.53,female,0.0,CHF,11.0,under $11k,10545.0,black,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2373047
60.65399,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,475387.0,white,137.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0224609
69.41797,male,1.0,Lung Cancer,14.0,$11-$25k,7194.0,asian,133.0,7.479492,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
25.89699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,251227.0,hispanic,136.0,7.389648,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
47.43298,male,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,169364.0,white,141.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0639648
36.29797,male,0.0,Cirrhosis,12.0,under $11k,48925.0,white,140.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
63.07999,male,0.0,CHF,14.0,under $11k,29706.0,hispanic,128.0,7.469727,135.0,23.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
61.77399,male,0.0,CHF,12.0,>$50k,21076.0,white,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.23297,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,233772.0,other,125.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7539062
72.42694,female,1.0,Cirrhosis,12.0,under $11k,69587.0,other,153.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1469727
80.38599,male,0.0,Colon Cancer,8.0,$25-$50k,11109.0,white,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.12695,male,1.0,Coma,14.0,under $11k,22541.0,white,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6728516
34.32199,female,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,271769.0,hispanic,136.0,7.359375,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
51.491,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,1056280.0,white,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.92499,female,0.0,CHF,5.0,under $11k,22303.0,hispanic,142.0,7.329102,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
71.95599,male,0.0,CHF,12.0,under $11k,35928.0,asian,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6972656
60.59097,female,0.0,Colon Cancer,12.0,$25-$50k,35397.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
33.09,male,1.0,MOSF w/Malig,12.0,under $11k,216416.0,asian,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6982422
74.74896,male,0.0,CHF,12.0,under $11k,10758.0,white,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0253906
50.90198,male,0.0,CHF,14.0,$25-$50k,37558.0,white,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.866,male,0.0,CHF,16.0,$25-$50k,68122.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.396,male,0.0,CHF,14.0,$25-$50k,9246.0,white,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
63.017,male,0.0,ARF/MOSF w/Sepsis,8.0,$25-$50k,133878.0,white,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
41.974,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,328134.0,white,142.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0996094
67.88495,male,1.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,181177.0,white,131.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
46.48297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,95454.0,white,141.0,7.30957,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9467773
64.51697,male,0.0,CHF,9.0,under $11k,125379.0,white,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,SIP>=30,0.4947999
65.711,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,497053.0,white,144.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
73.42896,male,0.0,CHF,12.0,>$50k,79641.0,white,137.0,7.259766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
34.05899,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,250630.0,black,133.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
32.40198,female,1.0,MOSF w/Malig,17.0,$25-$50k,262612.0,white,142.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
28.30099,male,0.0,CHF,12.0,under $11k,194198.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.690918
56.323,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,151266.0,white,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5961914
47.98099,female,0.0,Lung Cancer,18.0,under $11k,25024.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5249023
70.125,female,1.0,Coma,12.0,under $11k,96471.0,white,140.0,7.539062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3598633
35.31799,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,212409.0,black,134.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6660156
52.827,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,116166.0,white,145.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
68.64899,male,0.0,CHF,18.0,$11-$25k,75142.0,white,127.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
69.52795,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,122312.0,white,131.0,7.549805,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
63.05798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,600192.0,white,140.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.199707
66.09198,male,0.0,Lung Cancer,18.0,>$50k,8272.0,asian,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.48297,female,0.0,CHF,16.0,under $11k,19065.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.98599,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,864424.0,white,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4799805
85.862,female,1.0,COPD,12.0,$11-$25k,329169.0,white,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7705078
59.81097,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,401801.0,black,129.0,7.469727,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
56.65399,female,0.0,Colon Cancer,12.0,$25-$50k,61711.0,black,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2573242
82.086,male,0.0,CHF,12.0,$25-$50k,22899.0,other,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.9150391
33.5,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,158358.0,hispanic,130.0,7.379883,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
72.84094,male,0.0,Lung Cancer,12.0,under $11k,10314.0,white,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.465332
78.43695,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,106126.0,white,128.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5576172
78.00995,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,298193.0,white,130.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7758789
67.92596,female,0.0,Colon Cancer,12.0,under $11k,30406.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3935547
68.55597,male,0.0,CHF,14.0,$25-$50k,11855.0,white,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.421875
68.68195,male,0.0,Lung Cancer,12.0,$11-$25k,8686.0,white,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6171875
33.01297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,77603.0,white,146.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7485352
55.96399,male,0.0,Cirrhosis,14.0,$25-$50k,193362.0,white,146.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
79.45496,female,0.0,CHF,16.0,>$50k,13703.0,white,137.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
60.37198,male,0.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,234608.0,white,136.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.65796,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,477929.0,white,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7861328
95.66095,female,0.0,CHF,10.0,under $11k,12435.0,white,144.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
61.88098,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,777314.0,white,131.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3334961
72.35297,female,1.0,CHF,13.0,$11-$25k,25184.0,white,129.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7695312
57.93597,male,1.0,Cirrhosis,12.0,under $11k,29521.0,white,130.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8852539
47.82498,male,0.0,Cirrhosis,14.0,under $11k,29605.0,white,140.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.14899,male,0.0,CHF,12.0,under $11k,12331.0,white,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0800781
50.44998,female,1.0,Coma,12.0,under $11k,28491.0,white,140.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6328125
72.0,female,0.0,CHF,12.0,under $11k,40390.0,black,138.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5849609
65.92999,female,0.0,CHF,12.0,under $11k,60355.0,white,140.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
69.77997,male,0.0,CHF,16.0,$25-$50k,117036.0,white,133.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8129883
59.211,female,1.0,Lung Cancer,14.0,>$50k,8126.0,white,127.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
32.27698,female,1.0,MOSF w/Malig,16.0,>$50k,175267.0,white,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4165039
47.63898,female,0.0,Lung Cancer,13.0,under $11k,13877.0,white,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
74.26398,male,0.0,CHF,14.0,>$50k,35636.0,white,131.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
71.29895,male,1.0,Coma,14.0,under $11k,37330.0,white,132.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5908203
78.05096,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,167412.0,white,141.0,7.529297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
82.88599,male,0.0,CHF,14.0,$11-$25k,8568.0,white,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
55.37,male,0.0,CHF,16.0,$25-$50k,30070.0,white,132.0,7.419922,135.0,23.0,1968.0,1.0,4.0,no(M2 and SIP pres),4.0
63.53198,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,188077.0,other,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.53125
72.32599,male,0.0,Cirrhosis,19.0,$25-$50k,21341.0,white,133.0,7.489258,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.8486328
50.64499,male,0.0,Cirrhosis,14.0,$11-$25k,27047.0,white,130.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
44.37,female,1.0,Cirrhosis,11.0,$11-$25k,88231.0,white,147.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
52.75598,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25511.0,white,156.0,7.069336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9453125
63.27197,male,0.0,Lung Cancer,12.0,under $11k,11532.0,white,131.0,7.419922,135.0,23.0,1968.0,1.0,5.0,<2 mo. follow-up,5.0
68.20294,female,0.0,Colon Cancer,14.0,under $11k,133944.0,white,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.12598,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,127395.0,white,147.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0605469
71.11298,female,1.0,Lung Cancer,11.0,under $11k,9606.0,black,144.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7338867
63.836,female,0.0,CHF,12.0,>$50k,31055.0,white,136.0,7.299805,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
52.38599,male,0.0,MOSF w/Malig,14.0,under $11k,140565.0,white,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3676758
86.04199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,205980.0,white,144.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.646,female,0.0,CHF,13.0,under $11k,34235.0,white,142.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2436523
70.034,male,0.0,CHF,16.0,under $11k,6528.0,white,136.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
65.99896,female,0.0,Cirrhosis,11.0,under $11k,53190.0,white,131.0,7.419922,135.0,23.0,1968.0,5.0,5.0,SIP>=30,5.0
70.59296,male,0.0,Lung Cancer,12.0,under $11k,17079.0,asian,132.0,7.419922,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
49.99597,female,1.0,Coma,14.0,under $11k,712554.0,white,151.0,7.429688,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
62.89899,female,0.0,CHF,16.0,$11-$25k,12826.0,black,126.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1884766
55.87698,female,0.0,COPD,12.0,under $11k,55987.0,white,137.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9853516
42.237,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,41885.0,white,137.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
49.60999,female,0.0,Cirrhosis,14.0,>$50k,5215.0,white,139.0,7.419922,104.0,19.0,360.0,1.0,1.0,no(M2 and SIP pres),1.0
78.43695,female,0.0,COPD,12.0,under $11k,34499.0,white,140.0,7.339844,74.0,35.0,2600.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
55.98599,male,1.0,CHF,18.0,>$50k,90756.0,white,128.0,7.5,141.0,31.0,1875.0,0.0,0.0,<2 mo. follow-up,0.0
74.46698,female,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,161673.0,white,130.0,7.549805,116.0,3.0,3690.0,0.0,0.0,<2 mo. follow-up,0.0
44.90097,female,1.0,MOSF w/Malig,14.0,>$50k,307552.0,other,144.0,7.479492,433.0,40.0,1240.0,0.0,0.0,<2 mo. follow-up,0.0
44.383,male,0.0,ARF/MOSF w/Sepsis,20.0,>$50k,246214.0,white,145.0,7.489258,139.0,29.0,5040.0,0.0,1.0,<2 mo. follow-up,2.4560547
26.51299,female,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,87124.0,hispanic,133.0,7.5,114.0,7.0,6500.0,0.0,0.0,no(M2 and SIP pres),0.0
70.90796,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,390845.0,white,133.0,7.509766,213.0,65.0,5880.0,0.0,1.0,<2 mo. follow-up,3.4643555
63.64697,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,142625.0,white,137.0,7.459961,215.0,12.0,5605.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
72.54797,female,0.0,Colon Cancer,12.0,under $11k,10862.0,asian,138.0,7.419922,135.0,13.0,2125.0,0.0,1.0,<2 mo. follow-up,1.8320312
81.24298,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,172335.0,white,130.0,7.5,106.0,23.0,5075.0,0.0,2.0,no(M2 and SIP pres),2.0
34.59299,male,1.0,MOSF w/Malig,17.0,under $11k,118073.0,white,127.0,7.5,119.0,6.0,2159.0,0.0,7.0,<2 mo. follow-up,7.0
61.39398,male,0.0,CHF,14.0,$11-$25k,54893.0,white,129.0,7.419922,80.0,63.0,2375.0,0.0,2.0,<2 mo. follow-up,2.0
76.05499,male,0.0,CHF,14.0,under $11k,7626.0,white,139.0,7.419922,161.0,39.0,2390.0,6.0,1.0,no(M2 and SIP pres),4.5273438
49.49197,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,177889.0,white,147.0,7.469727,105.0,25.0,1480.0,0.0,7.0,no(M2 and SIP pres),7.0
78.03699,male,0.0,CHF,12.0,$11-$25k,35566.0,white,135.0,7.489258,90.0,71.0,650.0,5.0,1.0,<2 mo. follow-up,3.8549805
54.02298,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,676210.0,white,143.0,7.439453,74.0,95.0,160.0,0.0,0.0,<2 mo. follow-up,0.0
85.10297,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,62841.0,white,128.0,7.469727,353.0,20.0,2978.0,1.0,1.0,no(M2 and SIP pres),1.0
52.02197,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,593198.0,hispanic,145.0,7.419922,332.0,81.0,1760.0,0.0,7.0,no(M2 and SIP pres),7.0
86.62799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,96480.0,white,150.0,7.519531,357.0,16.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.95398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,298234.0,white,153.0,7.439453,182.0,76.0,1880.0,0.0,1.0,<2 mo. follow-up,3.206543
57.69699,male,0.0,Lung Cancer,16.0,>$50k,12827.0,white,141.0,7.419922,94.0,14.0,6360.0,0.0,1.0,no(M2 and SIP pres),0.494751
59.44397,male,1.0,Coma,24.0,>$50k,223643.0,white,144.0,7.509766,393.0,33.0,3050.0,0.0,0.0,<2 mo. follow-up,0.0
37.74698,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,577381.0,white,138.0,7.489258,129.0,71.0,12.0,0.0,3.0,<2 mo. follow-up,3.0
52.99698,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,174687.0,white,145.0,7.389648,658.0,98.0,0.0,0.0,1.0,<2 mo. follow-up,3.7827148
76.28497,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,141756.0,white,129.0,7.5,165.0,26.0,3450.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
57.53,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,261184.0,white,125.0,7.429688,841.0,66.0,895.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
70.20398,male,0.0,Lung Cancer,10.0,$25-$50k,10586.0,white,137.0,7.419922,135.0,5.0,5170.0,0.0,0.0,SIP>=30,0.0
66.04498,male,0.0,Lung Cancer,13.0,>$50k,11532.0,white,135.0,7.419922,135.0,15.0,5250.0,1.0,0.0,no(M2 and SIP pres),0.0
42.69397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,76504.0,white,130.0,7.449219,123.0,12.0,2000.0,0.0,1.0,<2 mo. follow-up,3.315918
44.23297,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,78031.0,hispanic,143.0,7.459961,101.0,26.0,4005.0,0.0,0.0,no(M2 and SIP pres),0.0
49.892,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,36044.0,white,140.0,7.419922,135.0,52.0,1350.0,0.0,3.0,<2 mo. follow-up,3.0
20.523,male,0.0,MOSF w/Malig,12.0,$11-$25k,784726.0,other,142.0,7.439453,251.0,30.0,3890.0,0.0,6.0,<2 mo. follow-up,6.0
62.5,female,0.0,Lung Cancer,9.0,under $11k,10163.0,white,138.0,7.419922,194.0,9.0,5700.0,5.0,1.0,no(M2 and SIP pres),3.8549805
37.47598,male,1.0,CHF,9.0,$11-$25k,270127.0,hispanic,131.0,7.419922,99.0,33.0,4275.0,1.0,0.0,<2 mo. follow-up,0.0
59.45499,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,976623.0,white,142.0,7.379883,135.0,75.0,238.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
66.26099,female,0.0,CHF,12.0,under $11k,11494.0,black,137.0,7.469727,251.0,23.0,3420.0,0.0,1.0,<2 mo. follow-up,4.8818359
59.03598,male,0.0,CHF,20.0,>$50k,21359.0,white,132.0,7.419922,100.0,43.0,1770.0,0.0,0.0,no(M2 and SIP pres),0.0
60.271,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,460668.0,white,143.0,7.419922,154.0,85.0,2850.0,0.0,3.0,<2 mo. follow-up,3.0
20.99699,male,1.0,Coma,14.0,under $11k,278242.0,asian,150.0,6.939453,335.0,75.0,110.0,0.0,1.0,<2 mo. follow-up,3.309082
55.655,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,34920.0,white,154.0,7.549805,111.0,63.0,2030.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
45.43698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,636886.0,white,134.0,7.299805,135.0,23.0,2050.0,0.0,1.0,<2 mo. follow-up,2.8330078
49.92499,male,0.0,Colon Cancer,17.0,>$50k,23578.0,white,140.0,7.419922,135.0,23.0,3450.0,0.0,0.0,no(M2 and SIP pres),0.0
42.11899,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,1086011.0,hispanic,147.0,7.449219,78.0,64.0,151.0,0.0,0.0,no(M2 and SIP pres),0.0
75.08795,male,1.0,Coma,12.0,under $11k,157000.0,white,153.0,7.239258,67.0,112.0,0.0,0.0,1.0,<2 mo. follow-up,3.8095703
44.32599,male,0.0,CHF,14.0,under $11k,44950.0,black,129.0,7.419922,154.0,51.0,2650.0,0.0,0.0,SIP>=30,0.0
75.17896,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,191750.0,white,142.0,7.449219,267.0,78.0,935.0,0.0,0.0,<2 mo. follow-up,0.0
51.452,female,0.0,Lung Cancer,12.0,$25-$50k,10606.0,white,138.0,7.419922,135.0,8.0,6150.0,0.0,0.0,no(M2 and SIP pres),0.0
62.37598,male,1.0,MOSF w/Malig,18.0,>$50k,139026.0,black,127.0,7.419922,186.0,101.0,1131.0,0.0,4.0,<2 mo. follow-up,4.0
54.47498,male,0.0,Lung Cancer,16.0,>$50k,94914.0,white,138.0,7.419922,165.0,12.0,7500.0,0.0,0.0,no(M2 and SIP pres),0.0
52.62997,male,0.0,Colon Cancer,12.0,under $11k,12265.0,white,132.0,7.419922,114.0,20.0,1075.0,0.0,1.0,no(M2 and SIP pres),1.857666
75.77496,female,0.0,CHF,13.0,under $11k,10782.0,white,137.0,7.419922,135.0,15.0,3450.0,0.0,1.0,<2 mo. follow-up,0.494751
76.961,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88755.0,hispanic,126.0,7.439453,159.0,30.0,7219.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
54.71597,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,31403.0,white,132.0,7.369141,119.0,56.0,970.0,2.0,2.0,<2 mo. follow-up,2.0
79.70398,female,1.0,MOSF w/Malig,16.0,$11-$25k,56752.0,white,135.0,7.459961,135.0,16.0,1870.0,0.0,1.0,<2 mo. follow-up,3.6772461
53.36099,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,314092.0,white,140.0,7.419922,286.0,96.0,7660.0,0.0,0.0,<2 mo. follow-up,0.0
73.94897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,208988.0,asian,135.0,7.509766,160.0,64.0,5055.0,0.0,1.0,<2 mo. follow-up,3.9243164
21.20999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,73268.0,hispanic,140.0,7.459961,135.0,9.0,1325.0,0.0,1.0,<2 mo. follow-up,1.0
86.35199,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,125804.0,white,131.0,7.379883,310.0,60.0,1262.0,0.0,0.0,<2 mo. follow-up,0.0
33.55197,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26882.0,black,133.0,7.429688,69.0,6.0,2060.0,0.0,1.0,no(M2 and SIP pres),3.2265625
64.58295,male,0.0,Lung Cancer,12.0,$25-$50k,5751.0,white,140.0,7.419922,92.0,11.0,2775.0,0.0,0.0,<2 mo. follow-up,0.0
79.54596,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30631.0,white,146.0,7.419922,189.0,11.0,422.0,0.0,1.0,<2 mo. follow-up,3.5649414
67.71497,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,46447.0,white,133.0,7.539062,95.0,11.0,2050.0,2.0,1.0,no(M2 and SIP pres),1.8388672
48.73599,female,0.0,Lung Cancer,12.0,under $11k,117616.0,white,135.0,7.419922,88.0,9.0,4735.0,0.0,1.0,<2 mo. follow-up,3.0268555
63.79498,female,0.0,Lung Cancer,16.0,>$50k,11253.0,white,140.0,7.419922,79.0,23.0,2200.0,4.0,1.0,adl>=4 (>=5 if sur),3.1831055
88.422,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,111560.0,white,146.0,7.479492,131.0,21.0,1975.0,0.0,1.0,<2 mo. follow-up,6.2734375
54.38199,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,508881.0,white,144.0,7.429688,140.0,99.0,619.0,0.0,2.0,<2 mo. follow-up,2.0
63.62198,male,0.0,CHF,14.0,under $11k,36522.0,white,131.0,7.419922,106.0,16.0,2960.0,0.0,1.0,no(M2 and SIP pres),1.0
35.52597,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,190585.0,white,149.0,7.449219,399.0,26.0,1770.0,0.0,0.0,<2 mo. follow-up,0.0
80.46295,male,0.0,CHF,16.0,>$50k,13833.0,white,142.0,7.419922,91.0,26.0,2500.0,1.0,1.0,no(M2 and SIP pres),1.0
44.02499,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35099.0,white,136.0,7.429688,106.0,19.0,3520.0,0.0,6.0,<2 mo. follow-up,6.0
35.26599,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,48956.0,white,148.0,7.319336,110.0,4.0,2870.0,6.0,6.0,SIP>=30,6.0
37.25098,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,83192.0,white,142.0,7.579102,110.0,49.0,0.0,0.0,1.0,<2 mo. follow-up,3.012207
62.133,male,1.0,CHF,12.0,>$50k,153171.0,white,132.0,7.419922,135.0,77.0,3885.0,0.0,1.0,<2 mo. follow-up,0.494751
32.64099,female,1.0,MOSF w/Malig,12.0,$11-$25k,358494.0,white,137.0,7.419922,307.0,70.0,3475.0,0.0,0.0,<2 mo. follow-up,0.0
76.44098,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,23486.0,white,131.0,7.40918,189.0,69.0,2560.0,0.0,0.0,no(M2 and SIP pres),0.0
77.59094,male,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,355655.0,white,142.0,7.279297,137.0,73.0,1035.0,0.0,1.0,<2 mo. follow-up,3.7192383
51.09698,male,0.0,Lung Cancer,16.0,under $11k,37350.0,white,130.0,7.399414,126.0,9.0,2547.0,0.0,0.0,<2 mo. follow-up,0.0
95.70697,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,16032.0,white,137.0,7.299805,395.0,44.0,20.0,0.0,1.0,<2 mo. follow-up,6.9287109
78.18799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,18497.0,white,139.0,7.589844,114.0,8.0,1650.0,0.0,1.0,<2 mo. follow-up,4.9316406
61.142,male,0.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,365437.0,black,136.0,7.469727,281.0,101.0,0.0,0.0,2.0,<2 mo. follow-up,2.0
84.99695,male,0.0,Coma,12.0,under $11k,19473.0,white,133.0,7.429688,170.0,20.0,850.0,0.0,1.0,<2 mo. follow-up,3.3886719
84.37195,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,64321.0,white,129.0,7.319336,157.0,30.0,3125.0,0.0,3.0,<2 mo. follow-up,3.0
77.99298,male,1.0,CHF,21.0,$25-$50k,90070.0,black,129.0,7.289062,108.0,73.0,162.0,0.0,1.0,<2 mo. follow-up,2.6665039
79.97797,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,121331.0,white,129.0,7.40918,97.0,87.0,2631.0,0.0,6.0,<2 mo. follow-up,6.0
79.06396,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,107076.0,white,145.0,7.449219,189.0,38.0,1559.0,0.0,0.0,<2 mo. follow-up,0.0
45.043,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,30354.0,white,124.0,7.719727,100.0,92.0,275.0,0.0,1.0,<2 mo. follow-up,1.6142578
50.155,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,372270.0,white,137.0,7.419922,330.0,111.0,3826.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
56.211,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,135949.0,white,139.0,7.459961,89.0,32.0,1965.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
51.18698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,56973.0,white,132.0,7.389648,164.0,13.0,3150.0,0.0,1.0,<2 mo. follow-up,2.8598633
47.95099,male,0.0,MOSF w/Malig,18.0,$11-$25k,53439.0,hispanic,134.0,7.369141,157.0,25.0,1450.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
100.24597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,51328.0,white,145.0,7.359375,49.0,18.0,0.0,0.0,1.0,<2 mo. follow-up,4.1796875
75.95294,male,1.0,Coma,17.0,$11-$25k,13525.0,white,135.0,7.40918,179.0,32.0,1600.0,0.0,1.0,<2 mo. follow-up,3.0849609
36.39398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,492853.0,black,150.0,7.419922,153.0,38.0,1467.0,0.0,5.0,<2 mo. follow-up,5.0
76.21399,female,0.0,COPD,14.0,under $11k,30490.0,white,143.0,7.299805,132.0,25.0,1600.0,2.0,3.0,no(M2 and SIP pres),3.0
87.05798,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,202508.0,white,131.0,7.5,156.0,55.0,2990.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
80.10095,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,299289.0,white,136.0,7.399414,152.0,19.0,4355.0,0.0,0.0,<2 mo. follow-up,0.0
62.724,female,1.0,Coma,18.0,$11-$25k,109193.0,white,133.0,7.489258,150.0,5.0,2495.0,0.0,1.0,<2 mo. follow-up,2.4272461
81.50897,male,0.0,CHF,12.0,under $11k,13004.0,white,140.0,7.419922,135.0,33.0,950.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
32.08499,male,0.0,CHF,12.0,under $11k,162263.0,hispanic,134.0,7.419922,103.0,27.0,4955.0,2.0,5.0,no(M2 and SIP pres),5.0
71.85498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,95439.0,asian,125.0,7.419922,135.0,71.0,2795.0,0.0,0.0,<2 mo. follow-up,0.0
90.20697,female,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,12549.0,white,137.0,7.25,390.0,38.0,600.0,0.0,1.0,<2 mo. follow-up,0.494751
67.92896,female,0.0,CHF,8.0,under $11k,82258.0,hispanic,134.0,7.419922,140.0,15.0,1890.0,1.0,1.0,SIP>=30,1.1667481
35.76498,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,94457.0,white,136.0,7.40918,104.0,11.0,3540.0,0.0,5.0,no(M2 and SIP pres),5.0
73.75494,female,1.0,Coma,12.0,under $11k,334890.0,hispanic,152.0,7.509766,314.0,17.0,4755.0,0.0,5.0,<2 mo. follow-up,5.0
54.004,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,748973.0,white,142.0,7.359375,163.0,95.0,525.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
52.51199,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,69096.0,white,136.0,7.359375,113.0,5.0,3400.0,0.0,3.0,no(M2 and SIP pres),3.0
38.168,female,0.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,151909.0,hispanic,151.0,7.259766,131.0,21.0,2665.0,0.0,1.0,SIP>=30,2.9682617
49.02399,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,64403.0,white,139.0,7.279297,164.0,83.0,645.0,0.0,0.0,<2 mo. follow-up,0.0
47.96198,male,0.0,COPD,14.0,under $11k,39258.0,white,136.0,7.40918,135.0,25.0,3950.0,1.0,1.0,<2 mo. follow-up,1.1667481
22.91299,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,59999.0,black,141.0,7.419922,156.0,35.0,1330.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
68.53894,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,246417.0,black,149.0,7.449219,166.0,13.0,2675.0,0.0,1.0,<2 mo. follow-up,2.4624023
94.80096,female,0.0,Lung Cancer,12.0,under $11k,11088.0,white,133.0,7.419922,108.0,28.0,700.0,0.0,1.0,<2 mo. follow-up,4.578125
47.88498,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,165774.0,black,144.0,7.419922,290.0,26.0,2761.0,0.0,1.0,<2 mo. follow-up,3.1933594
52.98599,male,0.0,CHF,12.0,under $11k,24044.0,white,136.0,7.419922,135.0,12.0,3960.0,0.0,1.0,no(M2 and SIP pres),1.0
41.26199,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,346799.0,white,141.0,7.5,252.0,30.0,2010.0,0.0,1.0,no(M2 and SIP pres),1.0
60.96899,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,156906.0,white,141.0,7.539062,97.0,27.0,4730.0,0.0,5.0,no(M2 and SIP pres),5.0
71.84698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,210555.0,white,133.0,7.399414,476.0,84.0,1941.0,0.0,1.0,<2 mo. follow-up,2.0454102
84.31799,male,0.0,ARF/MOSF w/Sepsis,18.0,>$50k,462018.0,asian,137.0,7.259766,135.0,29.0,1870.0,0.0,1.0,<2 mo. follow-up,2.8022461
38.21799,female,1.0,Coma,14.0,>$50k,97521.0,white,127.0,7.40918,135.0,24.0,3275.0,0.0,5.0,<2 mo. follow-up,5.0
79.15698,female,1.0,Coma,15.0,$25-$50k,16231.0,white,145.0,7.569336,273.0,19.0,1628.0,0.0,1.0,<2 mo. follow-up,3.6679688
33.59097,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,81881.0,hispanic,138.0,7.549805,120.0,38.0,2096.0,2.0,1.0,no(M2 and SIP pres),1.8388672
73.61798,male,1.0,MOSF w/Malig,16.0,>$50k,86043.0,white,134.0,7.509766,215.0,15.0,2410.0,0.0,5.0,<2 mo. follow-up,5.0
98.08899,female,1.0,Coma,16.0,under $11k,16613.0,white,139.0,7.549805,155.0,5.0,2525.0,0.0,1.0,<2 mo. follow-up,6.3632812
65.09497,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,358169.0,white,136.0,7.539062,152.0,12.0,4090.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
67.39197,female,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,213912.0,black,143.0,7.239258,286.0,62.0,5785.0,0.0,0.0,<2 mo. follow-up,0.0
69.77698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88609.0,white,136.0,7.459961,167.0,17.0,5420.0,0.0,1.0,<2 mo. follow-up,2.9160156
77.20496,female,0.0,COPD,12.0,under $11k,14068.0,white,134.0,7.199219,89.0,27.0,790.0,0.0,1.0,<2 mo. follow-up,3.659668
68.40796,female,0.0,COPD,12.0,under $11k,19252.0,white,141.0,7.369141,89.0,21.0,300.0,0.0,1.0,<2 mo. follow-up,4.4960938
74.25098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,205063.0,white,153.0,7.459961,93.0,100.0,7365.0,0.0,3.0,<2 mo. follow-up,3.0
35.92599,male,1.0,MOSF w/Malig,12.0,$25-$50k,389403.0,white,148.0,7.459961,135.0,101.0,210.0,0.0,0.0,<2 mo. follow-up,0.0
61.952,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,451954.0,white,143.0,7.469727,181.0,150.0,3060.0,0.0,1.0,Coma or Intub,3.0234375
75.87695,male,0.0,ARF/MOSF w/Sepsis,19.0,>$50k,39709.0,white,133.0,7.549805,135.0,25.0,4468.0,0.0,1.0,no(M2 and SIP pres),2.2265625
50.034,female,1.0,MOSF w/Malig,12.0,under $11k,60562.0,white,143.0,7.289062,166.0,36.0,6295.0,0.0,1.0,<2 mo. follow-up,3.3105469
66.90796,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,137219.0,white,132.0,7.509766,168.0,10.0,2620.0,0.0,5.0,<2 mo. follow-up,5.0
38.94299,female,1.0,Cirrhosis,12.0,under $11k,283724.0,asian,151.0,7.579102,261.0,65.0,1200.0,0.0,0.0,<2 mo. follow-up,0.0
32.07397,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,793804.0,hispanic,148.0,7.399414,296.0,33.0,2530.0,0.0,0.0,Coma or Intub,0.0
57.75198,female,0.0,CHF,11.0,under $11k,10350.0,black,139.0,7.419922,97.0,66.0,1350.0,1.0,1.0,SIP>=30,1.0
48.435,male,0.0,Colon Cancer,12.0,under $11k,18298.0,white,142.0,7.419922,0.0,13.0,3700.0,0.0,1.0,<2 mo. follow-up,2.5161133
56.50897,male,1.0,Coma,12.0,$11-$25k,25303.0,white,148.0,7.639648,126.0,30.0,3155.0,0.0,1.0,<2 mo. follow-up,2.1625977
48.47098,female,0.0,Lung Cancer,17.0,under $11k,41422.0,white,136.0,7.469727,184.0,9.0,2800.0,1.0,0.0,<2 mo. follow-up,0.0
23.24199,female,1.0,MOSF w/Malig,16.0,under $11k,636743.0,white,141.0,7.389648,135.0,115.0,3750.0,0.0,1.0,<2 mo. follow-up,2.65625
84.91394,male,0.0,CHF,16.0,under $11k,42792.0,white,137.0,7.469727,135.0,36.0,1000.0,6.0,2.0,<2 mo. follow-up,2.0
57.28998,male,1.0,MOSF w/Malig,14.0,>$50k,433153.0,white,138.0,7.429688,186.0,34.0,4203.0,0.0,0.0,<2 mo. follow-up,0.0
62.741,male,0.0,Cirrhosis,12.0,$11-$25k,17289.0,hispanic,133.0,7.419922,135.0,23.0,1150.0,1.0,1.0,no(M2 and SIP pres),1.1667481
73.91595,female,0.0,Colon Cancer,12.0,under $11k,37120.0,white,133.0,7.419922,139.0,12.0,1410.0,0.0,5.0,<2 mo. follow-up,5.0
62.34598,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,54050.0,white,146.0,7.55957,145.0,56.0,2540.0,0.0,0.0,<2 mo. follow-up,0.0
19.765,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,hispanic,135.0,7.369141,302.0,71.0,1707.0,0.0,1.0,<2 mo. follow-up,2.1357422
62.965,male,0.0,CHF,12.0,under $11k,32473.0,white,139.0,7.419922,104.0,50.0,1175.0,0.0,1.0,<2 mo. follow-up,3.5175781
51.98398,male,0.0,Colon Cancer,14.0,>$50k,30678.0,white,140.0,7.419922,169.0,23.0,740.0,0.0,0.0,<2 mo. follow-up,0.0
78.62,female,0.0,Lung Cancer,12.0,under $11k,20276.0,white,126.0,7.579102,100.0,20.0,600.0,1.0,1.0,<2 mo. follow-up,1.1667481
46.51898,female,1.0,Coma,12.0,under $11k,79492.0,black,127.0,7.30957,88.0,49.0,3620.0,0.0,1.0,<2 mo. follow-up,3.140625
60.16699,male,1.0,MOSF w/Malig,12.0,under $11k,142620.0,white,143.0,7.489258,154.0,9.0,2310.0,0.0,2.0,<2 mo. follow-up,2.0
33.01297,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25024.0,white,153.0,7.429688,256.0,115.0,2500.0,0.0,1.0,<2 mo. follow-up,3.2822266
53.71899,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,651870.0,white,135.0,7.5,235.0,77.0,2.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
38.87698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,282625.0,white,142.0,7.509766,291.0,23.0,1405.0,0.0,1.0,SIP>=30,3.0825195
61.689,male,0.0,Colon Cancer,12.0,under $11k,16468.0,white,135.0,7.419922,135.0,16.0,4520.0,0.0,1.0,<2 mo. follow-up,2.4331055
69.125,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,64500.0,white,140.0,7.40918,135.0,23.0,540.0,0.0,2.0,no(M2 and SIP pres),2.0
30.98399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,175051.0,white,144.0,7.449219,127.0,17.0,2915.0,0.0,1.0,<2 mo. follow-up,2.6137695
62.75998,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,985215.0,white,146.0,7.509766,349.0,59.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
62.28897,male,0.0,Colon Cancer,12.0,under $11k,34721.0,white,140.0,7.419922,135.0,23.0,1900.0,0.0,0.0,<2 mo. follow-up,0.0
38.94299,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,147307.0,white,135.0,7.399414,330.0,22.0,1360.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
53.314,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,517087.0,asian,137.0,7.479492,228.0,19.0,3079.0,0.0,1.0,SIP>=30,3.1201172
67.63898,male,0.0,Lung Cancer,12.0,under $11k,21057.0,white,135.0,7.419922,135.0,12.0,2595.0,0.0,0.0,SIP>=30,0.0
57.34698,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,139549.0,hispanic,136.0,7.399414,508.0,23.0,4170.0,0.0,6.0,no(M2 and SIP pres),6.0
40.14798,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,172266.0,white,145.0,7.449219,154.0,61.0,3550.0,0.0,0.0,no(M2 and SIP pres),0.0
60.37,female,0.0,Colon Cancer,12.0,>$50k,8439.0,white,136.0,7.419922,99.0,6.0,3550.0,0.0,0.0,no(M2 and SIP pres),0.0
22.741,male,0.0,Coma,17.0,$25-$50k,150904.0,hispanic,145.0,7.549805,93.0,32.0,3290.0,0.0,0.0,no(M2 and SIP pres),0.0
33.67798,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,758539.0,black,147.0,7.469727,350.0,66.0,3025.0,0.0,0.0,<2 mo. follow-up,0.0
71.29095,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,117388.0,black,146.0,7.449219,199.0,65.0,753.0,0.0,1.0,<2 mo. follow-up,2.4750977
59.452,female,0.0,Colon Cancer,12.0,under $11k,27070.0,white,135.0,7.419922,135.0,13.0,2025.0,0.0,2.0,no(M2 and SIP pres),2.0
74.97894,female,1.0,MOSF w/Malig,18.0,$25-$50k,60987.0,white,135.0,7.489258,178.0,21.0,18.0,0.0,2.0,<2 mo. follow-up,2.0
75.67999,male,1.0,MOSF w/Malig,16.0,$25-$50k,122270.0,white,140.0,7.5,183.0,29.0,3102.0,0.0,0.0,<2 mo. follow-up,0.0
65.26196,female,0.0,Lung Cancer,12.0,>$50k,35260.0,white,139.0,7.419922,91.0,13.0,2050.0,1.0,1.0,no(M2 and SIP pres),1.0
65.74896,female,0.0,CHF,12.0,$11-$25k,34253.0,white,132.0,7.419922,119.0,17.0,5395.0,5.0,1.0,<2 mo. follow-up,3.8549805
75.97296,male,0.0,CHF,16.0,$25-$50k,51180.0,white,142.0,7.419922,150.0,34.0,50.0,3.0,3.0,<2 mo. follow-up,3.0
72.33899,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,146792.0,white,135.0,7.389648,149.0,18.0,1615.0,0.0,1.0,<2 mo. follow-up,1.0
70.62299,male,0.0,Lung Cancer,12.0,$25-$50k,48292.0,white,129.0,7.419922,148.0,19.0,3250.0,0.0,0.0,<2 mo. follow-up,0.0
61.80698,female,0.0,COPD,20.0,>$50k,17086.0,white,131.0,7.389648,135.0,17.0,2400.0,1.0,0.0,<2 mo. follow-up,0.0
68.758,female,0.0,Colon Cancer,16.0,under $11k,24338.0,white,136.0,7.419922,122.0,4.0,4450.0,0.0,0.0,<2 mo. follow-up,0.0
32.616,female,0.0,CHF,12.0,$11-$25k,8228.0,white,139.0,7.419922,113.0,14.0,2150.0,0.0,0.0,no(M2 and SIP pres),0.0
78.48596,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,168174.0,white,125.0,7.55957,101.0,17.0,1660.0,0.0,1.0,<2 mo. follow-up,3.2768555
41.64798,female,0.0,Colon Cancer,14.0,>$50k,16011.0,white,140.0,7.419922,135.0,23.0,1350.0,0.0,0.0,<2 mo. follow-up,0.0
55.58398,female,0.0,MOSF w/Malig,11.0,$11-$25k,25024.0,white,126.0,7.349609,188.0,22.0,6865.0,0.0,1.0,SIP>=30,2.9018555
64.32898,male,0.0,Lung Cancer,12.0,under $11k,7735.0,white,141.0,7.419922,85.0,28.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3125
77.77698,female,1.0,Coma,16.0,under $11k,63572.0,white,132.0,7.379883,273.0,70.0,4352.0,0.0,1.0,<2 mo. follow-up,1.0
82.98999,male,0.0,CHF,8.0,$11-$25k,51711.0,white,139.0,7.419922,113.0,32.0,4750.0,0.0,0.0,no(M2 and SIP pres),0.0
72.77496,female,0.0,CHF,12.0,under $11k,28137.0,black,135.0,7.419922,120.0,17.0,1170.0,3.0,4.0,adl>=4 (>=5 if sur),4.0
70.04498,female,0.0,COPD,9.0,under $11k,119685.0,black,148.0,7.349609,330.0,22.0,982.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
